WO2013055070A2 - Plasma extraction kit - Google Patents
Plasma extraction kit Download PDFInfo
- Publication number
- WO2013055070A2 WO2013055070A2 PCT/KR2012/008148 KR2012008148W WO2013055070A2 WO 2013055070 A2 WO2013055070 A2 WO 2013055070A2 KR 2012008148 W KR2012008148 W KR 2012008148W WO 2013055070 A2 WO2013055070 A2 WO 2013055070A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extraction kit
- prp
- plasma
- plasma extraction
- blood
- Prior art date
Links
- 238000000605 extraction Methods 0.000 title claims abstract description 83
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 70
- 210000004369 blood Anatomy 0.000 claims abstract description 63
- 239000008280 blood Substances 0.000 claims abstract description 63
- 238000005119 centrifugation Methods 0.000 claims abstract description 31
- 238000002347 injection Methods 0.000 claims abstract description 16
- 239000007924 injection Substances 0.000 claims abstract description 16
- 238000003860 storage Methods 0.000 claims abstract description 12
- 230000007423 decrease Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 14
- 238000000926 separation method Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 14
- 230000001954 sterilising effect Effects 0.000 abstract description 9
- 239000012503 blood component Substances 0.000 abstract description 4
- 238000011109 contamination Methods 0.000 abstract description 3
- 208000000283 familial pityriasis rubra pilaris Diseases 0.000 description 84
- 210000002381 plasma Anatomy 0.000 description 50
- 210000001772 blood platelet Anatomy 0.000 description 13
- 239000000306 component Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 210000000601 blood cell Anatomy 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 238000012937 correction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010061307 Neck deformity Diseases 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000001700 effect on tissue Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003634 thrombocyte concentrate Substances 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/042—Caps; Plugs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/046—Function or devices integrated in the closure
- B01L2300/049—Valves integrated in closure
Definitions
- the present invention relates to a plasma extraction kit, and more particularly, a device used to separate and extract a specific component of blood, to increase the concentration and purity of a specific component to be extracted and to easily extract a specific component from the blood.
- the present invention relates to a plasma extraction kit that is easy to disinfect and convenient.
- blood cells in the blood are mixed with different specific gravity components, when centrifuged to form a layer by each type.
- PRP platelet rich plasma
- 'PRP' Platelet Rich Plasma Platelet Rich Plasma
- Platelets have a regenerative effect because platelet cells contain abundant growth factors. Injecting high levels of platelets into the treatment area causes platelet growth factors to activate stem cells to regenerate damaged tissue. The higher the concentration of PRP, the greater the therapeutic effect.
- the general PRP extraction process first collects blood from the human body and centrifuges it. Several cells are mixed in the blood. When centrifuged, homogeneous cells are collected and layered according to specific gravity.
- the blood consists of a solution component and a blood cell component (grain cell), which contains red blood cells, white blood cells, platelets, and a very small amount of antibodies, which are mixed and floated in a solution with 0.9% salinity. Red blood cells constitute the majority of the blood cell components.
- the blood When the blood is centrifuged, it is separated into three layers.
- the heaviest red blood cells are collected at the bottom of the centrifuge tube, and platelets and leukocytes are gathered on the upper layer to form a thin layer. Missing solution components are placed.
- the platelet and leukocytes are concentrated together, and the thin layer is called PRP, and the plasma layer composed only of solution without blood cell granules above is called PPP (Platelet Poor Plasma). .
- Patent Document 1 Korean Registered Patent No. 1016166 (Method for separating autologous platelet concentrate)
- Patent Document 2 Korean Registered Patent No. 1043231 (centrifugal separation method and adapter used therein)
- Patent Document 3 Korean Registered Patent No. 1029255 (centrifugal separator)
- the PRP appears as a very thin layer, which appears to be thin and widely spread over the entire red blood cell layer directly below, and the thickness of the red blood cell that is collected at the bottom is different depending on the person. Since the ratio of the total volume of the whole blood varies from as little as 25% to as much as 50%, it is not easy to extract high purity PRP.
- the needle In order to extract PRP thinly spread on the top of the erythrocyte layer, the needle is inserted into the test tube, and the tip of the needle touches the PRP layer and is extracted by inhaling it. In the process, a significant number of red blood cells are sucked in with the PRP, and these red blood cells are injected into the tissue along with the PRP when the patient is treated.
- Erythrocytes sucked into PRP cause two problems. First, the higher the amount of red blood cells, the lower the concentration of PRP, which lowers the therapeutic effect. Second, the patients complain of severe pain after the procedure. Cause. Even with pure PRP, there is some pain after treatment, which lasts as long as 1 day and as long as 1 week. In some cases, narcotic analgesics may be required. When the red blood cells are injected together, the pain becomes more severe. For this reason, several methods are used to prevent the inclusion of red blood cells in PRP extraction. The most commonly used method is to reduce the diameter of the centrifuge tube in the area where the PRP layer is expected to form and to reduce the proportion of PRP.
- a correction device that adjusts the height of the red blood cell layer in the lower part of the separator to position the PRP in the narrow neck portion should be accompanied.
- a screw-shaped stopper in the lower part of the centrifuge tube may be locked or released depending on the situation. Rotating in the direction to control the height of the red blood cell layer.
- the centrifuge tube of this type has a great escape pressure of blood in the lower part of the centrifuge tube during the high-speed rotation of 3000-4000RPM, and there is a possibility that blood can flow out through the screw part.
- a piston is inserted into the upper part to be movable, the lower portion is formed with a needle connector is fixed to the needle, the inside is filled with a certain amount of serum separation gel for separating blood and serum therein;
- a protrusion which protrudes above the needle connector formed in the lower portion of the cylinder and is formed inside the cylinder so that the serum separation gel filled in the syringe is not discharged toward the needle connector where the needle is fixed;
- a lower stopper which is fixed to the lower part of the needle connector when the needle is removed from the needle connector of the cylinder to which the needle is fixed, and a seal which seals the needle connector protrudes upward;
- the cylinder is sealed by an upper cap.
- a method of sterilization by high temperature steam As a disinfection method of such a medical device, a method of sterilization by high temperature steam, a method of sterilizing by adding EO gas, and a method of sterilizing by irradiating gamma rays are mainly used.
- sterilization by high temperature steam not only is it difficult to apply to plastic products, but also has a problem of being difficult to sterilize in a sealed state. It is difficult to disinfect the inside of medical devices because it is released in the state, and the sterilization method that irradiates gamma rays can be applied to plastic products, but it is difficult to apply to plastic products and the manufacturing cost becomes expensive because special treatment must be performed to endure gamma rays. There was a problem.
- the present invention is to solve the above-mentioned problems of the prior art, an object of the present invention is not only capable of disinfection in a sealed syringe or plasma extraction kit manufactured at the factory, but also when injecting the blood extracted from the patient into the kit It is to provide a plasma extraction kit that is less concerned about contamination and easy to inject and seal.
- another object of the present invention is to provide a plasma extraction kit in which the extracted PRP is increased in purity and concentration, the ease of extraction operation is further improved, and the manufacturing cost can be reduced.
- the upper end is opened and the lower end is closed with a cylindrical body portion, and fastened to the inner central portion of the main body portion, the diameter of the central portion is small and both ends It characterized in that it comprises a funnel portion formed in a tapered shape that gradually decreases in diameter toward the central portion, and a cover portion for closing the upper end of the main body portion.
- the present invention is the second centrifugal to further extract the plasma by the second centrifugation from the PPP and erythrocytes of the centrifuged blood after the first centrifugation of the blood injected by the plasma extraction kit for extracting the plasma components from the blood Characterized in that comprises a separator tube.
- the present invention having the above-described configuration, it is possible to easily extract a high-purity high concentration of PRP, can be extracted by almost eliminating red blood cells in the extraction process, the degree of variation is small according to the operator and the extraction time can be shortened By lowering the manufacturing cost of the centrifuge tube, there is an advantage that can reduce the treatment cost of the operators. After centrifugation, a large amount of red blood cells in the blood component is accommodated in the blood storage unit, and a small amount of PRP can be accommodated in the center of the funnel having a small diameter, thereby facilitating extraction of a small amount of PRP.
- the PRP can be accurately positioned in the funnel, thereby easily extracting high-purity PRP with high purity and red blood cells in the extraction process.
- the extraction can be almost excluded, and the degree of variation according to the operator is small, the extraction time can be shortened, and the manufacturing cost of the centrifuge tube can be lowered to reduce the treatment cost of the operators.
- FIG. 1 is a view showing a plasma extraction kit of the prior art
- FIG. 2 is a view showing a plasma extraction kit according to a first embodiment of the present invention
- FIG. 3 is a perspective view and a cross-sectional view of the plasma extraction kit of the first embodiment
- FIG. 4 is a perspective view and a cross-sectional view of the funnel to be inserted into the plasma extraction kit of the first embodiment
- FIG. 6 is a cross-sectional view showing the first PRP and PPP extraction
- FIG. 7 is a cross-sectional view showing the appearance of excess red blood cells after the first centrifugation
- Figure 8 is a cross-sectional view showing the appearance of red blood cells under the first centrifugation
- FIG. 11 is a cross-sectional view showing the extraction of the PPP of the upper layer
- FIG. 12 is a cross-sectional view showing a small amount of remaining PPP, PRP, small amount of red blood cells,
- FIG. 13 is a cross-sectional view showing a state of extracting the final PRP
- FIG. 14 is a perspective view showing a plasma extraction kit according to a second embodiment of the present invention.
- FIG. 15 is a cutaway perspective view of FIG. 14; FIG.
- FIG. 16 is a cross-sectional view of the plasma extraction kit according to a second embodiment of the present invention.
- 17 and 18 are views showing the outer cylinder of the plasma extraction kit according to a second embodiment of the present invention.
- FIG. 19 is a view showing the opening and closing cap of the plasma extraction kit according to a second embodiment of the present invention.
- FIG. 20 is a view showing a cover portion of the plasma extraction kit according to a second embodiment of the present invention.
- 21 is a view showing the connection blade portion of the plasma extraction kit according to a second embodiment of the present invention.
- FIG. 22 is a diagram showing an example of use of the plasma extraction kit according to the second embodiment of the present invention.
- Plasma extraction kit the upper end is opened and the lower end is closed, the main body portion is fastened to the inner central portion of the main body portion, the diameter of the center portion is small and both ends are gradually reduced in diameter toward the center portion A funnel formed in a tapered shape, and a cover portion for closing the upper end of the main body portion.
- the inner side of the main body portion is characterized in that the locking step is formed to prevent the separation to maintain the funnel in a predetermined position.
- the opening and closing is fastened to the cover portion, characterized in that it comprises an opening and closing cap having an injection hole on one side that can be inserted into the needle of the syringe for injecting blood extracted from the patient.
- the opening and closing cap and closes the opening formed in the center of the upper surface, characterized in that it further comprises a sealing membrane formed of a material that can be easily inserted into the syringe for extracting the multi-platelet plasma of the centrifuged blood.
- the cover part has a fastening hole formed at the center thereof, and includes a protrusion projecting from the fastening hole, and the opening / closing cap is provided with a locking protrusion projecting outward from the lower end to be locked to the protrusion of the cover part.
- the funnel characterized in that it further comprises a blood storage unit for receiving the blood is installed is installed in the inner bottom of the main body portion.
- the funnel is formed of an inner cylinder formed in a tapered shape in which the diameter of the center portion is small and both ends thereof are tapered in diameter gradually decreasing toward the center portion, and an outer cylinder formed in a hollow cylindrical shape in which upper and lower portions are opened and both ends of the inner cylinder are fastened. It is characterized by.
- the outer cylinder is formed with a fastening protrusion protruding outward, the inner surface of the main body portion is indented concave inwardly and has a predetermined width, the fastening protrusion is inserted into the fastening groove for limiting the movement of the fastening protrusion is It is characterized by being formed.
- one end is connected to the funnel and the other end is bent and characterized in that it further comprises an elongated rod-shaped connecting blade formed with a fastening projection engaging the thread of the cover portion.
- connection blade portion is characterized in that it comprises a first wing portion formed in a T-shape at one end, and a connecting projection fastened to the fastening screw formed on the cover portion at the other end.
- the upper end portion of the outer cylinder is formed by cutting in a T-shape and characterized in that it further comprises a locking groove that is fastened to the first wing portion.
- the second centrifugal centrifugation to further extract the plasma from the PRP, PPP and erythrocytes of the centrifuged blood by centrifugation of the injected blood first Characterized in that further comprises a separation tube.
- the secondary centrifuge tube is formed in a cylindrical shape, the lower end of the secondary centrifuge tube is formed with a second capillary tube having a smaller diameter than the upper portion, the tip portion of the second capillary tube is gradually reduced in diameter is formed It is characterized by being.
- FIG. 2 to 13 is a view showing a plasma extraction kit according to a first embodiment of the present invention.
- the plasma extraction kit 1 is provided as two centrifuge tube cylinders of different shapes, respectively, used as a main body portion, secondary centrifuge tube, each The shape is provided as designed to be easily used in the extraction process.
- the inlet of the main body and the secondary centrifuge tube which will be described later, is closed by lids 40 and 40 ', and the central portion of the lid is formed with perforations 42 and 42' through which a needle can enter. It is configured to inject blood by inserting a needle through the drilling hole without removing the upper cover, the cover is formed of a soft elastic material to be safe from external infection.
- the above-described cover has a portion to be inserted into the main body portion, the surface of which is formed with threads 41 and 41 '.
- a funnel portion 20 formed in a cylindrical shape is inserted into the main body portion, and a capillary tube 23 having a long narrow diameter penetrating the upper and lower portions of the funnel portion is formed in the center of the funnel portion 20.
- the upper and lower ends of the capillary are formed with funnel-shaped tapered portions 21 and 22 that are narrower or wider in diameter, and the main body and the funnel are formed of a transparent material and are located in the inner capillary from the outside. Blood components can be seen clearly.
- the inserted funnel is provided in close contact with the inner diameter of the main body portion accurately.
- the inclination of the funnel-shaped taper is designed differently for the upper and lower parts.
- two narrow, long rod-shaped connecting wings 24 extend upward, leading to the cover, the end of which is bent inward to form a fastening protrusion 25 to form a screw thread at the bottom of the cover. It is provided in a state capable of being bitten by 26.
- the funnel portion of the lower portion connected to the connecting wing part is changed in height while moving up and down along the thread of the cover.
- the side of the cover is made of irregularities (43) to increase the friction force during rotation
- the funnel When the funnel is connected to the cover by a wing, it is floating in the middle without descending to the bottom of the main body.
- the top and bottom of the cylinder of the portion where the funnel is located is provided with a locking jaw 27 is spaced by a predetermined distance so that the cylindrical structure does not reach the floor or come out of the upper limit.
- the lower space of the funnel portion is a space in which red blood cells are collected during centrifugation, and the blood storage unit 30 calculates the diversity of red blood cells of each person and secures a space of appropriate capacity.
- the secondary centrifuge tube (2) is formed in a substantially cylindrical shape, the lower end of which is formed a narrow second capillary tube (71) having a smaller diameter than the upper portion, and the end of the second capillary tube (71) is conical. As the diameter becomes smaller, the tip portion 72 is formed which ends at the vertex.
- Centrifugation to extract the PRP is usually carried out twice. After the first centrifugation, the ratio of the upper plasma and the lower red blood cells is measured, and the position is adjusted. Then, the second centrifugation is performed. The products developed so far are performed twice in an integrated centrifuge tube.
- the plasma extraction kit according to the present embodiment is characterized in that the first centrifugation and the second centrifugation are performed in different centrifuge tubes.
- the plasma extraction kit 1 of the present embodiment is designed to accommodate the range of this deviation and facilitate extraction.
- the plasma extraction kit 1 is divided into an upper space 10, a funnel 20, and a blood storage unit 30 from above.
- the upper space 10 is a section where plasma is collected
- the blood storage unit 30 is a space where red blood cells are collected
- the funnel 20 is designed to form a boundary of two layers.
- the upper end 21 and the lower end of the funnel are formed with funnel-shaped tapered parts 21 and 22 that are gradually smaller or larger in diameter so that the blood cell components can be moved well during centrifugation.
- the plasma extraction kit has a capacity designed so that the red blood cells in the range showing the distribution of the upper and lower 80-90% of the total based on the average red blood cells can be accommodated in the lower space and the narrow and long capillary 23 of the funnel. It is. Therefore, after the first centrifugation, the position of the uppermost layer of red blood cells is located in any part of the capillary. Immediately above, the PRP is densely packed and thickened as the cross-sectional area of the centrifuge tube is reduced. In this case, the needle is inserted directly without the need for height adjustment of the funnel to extract all of the upper PPP including the PRP at once.
- the cover 41 is turned to turn the height of the inner tube.
- PRP layer is located in any part of the capillary and PRP and PPP are extracted in the manner described above.
- the length of the capillary tube is very long, so even if the position adjustment is a little, the position of the PRP falls within the acceptance range of the capillary tube, which is much easier to extract than the narrow capillary product.
- the extracted PPP, PRP and a small amount of sucked red blood cells are transferred to the secondary centrifuge tube (2) and subjected to secondary centrifugation.
- the secondary centrifuge tube 2 is formed in a substantially cylindrical shape, and at the lower end thereof, a narrow second capillary tube 71 having a smaller diameter than the upper portion is formed, and the second capillary tube 71 is formed.
- a conical shape is made smaller in diameter and ends are formed with a tip portion 72 ends with a vertex.
- Centrifugation with this specially designed secondary centrifuge tube forms PPP, PRP, and a small amount of red blood cells inhaled from the top.
- the lowest red blood cells are all contained within the tip portion 72 of the secondary centrifuge tube.
- the needle touches the PRP layer and extracts the remaining liquid except the lower red blood cells, and since the lower red blood cells are collected only in a very narrow space, it is possible to extract only a small amount of PPP and PRP with very little touch without extracting them. High concentration PRP can be obtained.
- Another method is to first extract the red blood cells and discard them by inserting the needles into the red blood cell layer of the uppermost space of the bottom layer, and then extracting and discarding the upper layer of PPP, leaving only a small amount of PPP and PRP. This ensures high purity and high concentration of PRP treatment solution by extracting all the remaining solution in the cylinder all at once without the need for timely extraction.
- Another advantage of using this device is the ability to control the concentration of PRP.
- concentration of PRP changes according to the amount of PPP remaining.
- the number of platelets in a normal person is about 100,000 to 200,000 per microliter, but the concentration should be concentrated to more than 1 million, which is five times that of PRP.
- PRP is extracted including a small amount of PPP in order to secure an appropriate volume of PRP injection. If you want to extract different concentration rates, adjust the amount of PPP remaining when extracting PPP in the upper layer after the second centrifugation. Just do it. If you leave a lot of PPP, the dose of the final treatment injection will increase, but it will be a low concentration of PRP. If you leave less PPP, you will get a high concentration of PRP, although the dose of treatment injection is small.
- the question of how much the final treatment dose is to be determined is determined by the treating physician according to the area of the treatment site.
- the use of this device has the advantage that the concentration control can be very simple.
- Both the main body and the secondary centrifuge tube are made of a closed type with no connecting part, so it is also characterized by a robust structure without fear of blood leakage by high-speed rotation.
- Extracting PRP using the plasma extraction kit according to the present embodiment has the following advantages.
- the capillary is tapered up and down, and the central part is elongated to accommodate most of the variation due to the change in red blood cell volume, so that no time is required to extract PRP.
- erythrocytes included in the extraction of PRP and PPP after the first centrifugation can be excluded through the second centrifuge tube, so that PRP can be extracted without high erythrocytes.
- the fourth designed second centrifuge tube can be used to control the concentration of PRP as described above.
- the main body and the second centrifuge tube are designed to be operated without opening the lid, which is safe against external infection.
- the seventh lower part is simpler in structure compared to the existing blood separation device with a height adjusting screw, and thus can be manufactured at a low cost.
- FIG 14 to 22 are diagrams showing the plasma extraction kit 100 according to the second embodiment of the present invention.
- the plasma extraction kit is the main body 110, the cover 120, the blood storage 130, the funnel 140, 141, Connection wing unit 150, and includes an opening and closing cap 160.
- the main body 110 is formed in a cylindrical shape with an upper end opened and a lower end closed.
- the material of the main body 110 is not particularly limited, but in the present embodiment, the material is made of a plastic material having low manufacturing cost and easy manufacturing.
- a fastening groove 110b is formed at the center of the inner surface of the main body 10.
- the fastening groove 110b is formed to be concavely cut away from the inner side of the main body, and is formed to have a constant width without being formed over the entire circumference of the inner side of the main body.
- the funnel portion to be described later is placed on the stepped portion 110a formed at the bottom of the fastening groove 110b, and the rotation of the funnel portion by the movement of the connection blade to be described later is performed by the fastening groove. It is configured to be limited by the width.
- An upper portion of the main body portion is provided to seal the main body portion with a sealing member 110c such as a packing or an O-ring interposed between the main body portion and a cover portion described later.
- a sealing member 110c such as a packing or an O-ring interposed between the main body portion and a cover portion described later.
- the blood storage unit 130 is accommodated in the inner lower end of the main body.
- the blood reservoir is formed in a cylindrical shape with an upper end opened and a lower end closed, and is hermetically received inside the main body.
- the blood storage unit 130 receives the red blood cell portion of the blood after centrifugation of the injected blood.
- Funnels 140 and 141 are installed above the blood storage unit in the main body.
- the funnels 140 and 141 are fastened to the inner central portion of the main body, and as shown in FIGS. 15 and 16, the diameter of the central portion is small and both ends are formed in a tapered shape in which the diameter gradually decreases toward the central portion.
- the quality of the extract may vary, but according to the present invention, after centrifugation, a large amount of red blood cells in the blood component is accommodated in the blood storage unit, and a small amount of PRP can be accommodated in the center of the funnel having a small diameter. Even if a small amount of PRP is accommodated in the central portion of the funnel having a small diameter, it is possible to easily extract high-purity high concentrations of PRP, and almost eliminate red blood cells in the extraction process.
- the funnel portion may be formed as one unit, but in the case of injection molding of plastic material, the inner portion of the central portion having a small diameter may cause a defect such as the generation of bubbles due to the occurrence of a defect.
- the inner portion of the central portion having a small diameter may cause a defect such as the generation of bubbles due to the occurrence of a defect.
- it is formed separately from the outer cylinder 140.
- the inner cylinder 141 is formed in a tapered shape in which the diameter of the central portion is small and both ends gradually decrease in diameter toward the central portion.
- the outer cylinder 140 is formed in a hollow cylindrical shape of the upper and lower openings, the lower end of the outer cylinder is formed to extend inward to protrude, the seating groove 140b is provided on the upper end of the protruding portion.
- the lower end of the tapered shape of the inner cylinder is inserted and seated in the seating groove 140b so that the inner cylinder and the outer cylinder are integrally connected to each other.
- the outer cylinder 140 has a fastening protrusion 140a protruding outward from the outer surface of the outer cylinder along the longitudinal direction of the outer cylinder.
- the fastening protrusion 140a is inserted into the fastening groove 110b of the main body.
- the locking fixing groove 140c is formed by cutting in an inverted T shape from the upper end of the outer cylinder.
- the locking blade groove (140c) is inserted so that the first wing portion of the connecting blade portion to be described later is configured so that the connecting blade portion and the outer cylinder behave integrally.
- connection blade when the connection blade is connected to the upper end of the outer cylinder, and the connection blade is screwed to the cover portion as described below, when the cover portion rotates, the connection blade portion and the outer cylinder connected thereto are rotated.
- the fastening protrusion of the outer cylinder is rotated by the width of the fastening groove in the state inserted into the fastening groove of the main body portion is blocked by the end of the fastening groove, thereby the outer cylinder is stopped rotation is the connection blade It is configured to move the position from the inside of the main body portion to the upper or lower by the rotation of the cover portion in a fixed state.
- the PRP can be accurately positioned in the funnel part, whereby a small amount of PRP has a diameter. It can be accommodated in the center of a small funnel, and even if a small amount of PRP is accommodated in the center of a small funnel, it can easily extract high-purity PRP with high purity and almost eliminate red blood cells in the extraction process. .
- connection wing 150 is one side is fastened to the cover portion, the other side is fastened to the outer cylinder.
- the connecting wing unit 150, the first wing portion 152 is formed in a portion that is fastened with the outer cylinder, the connection protrusion 151 is formed on the side that is fastened to the cover portion.
- the first wing portion 152 protrudes outward from the width of the connecting wing portion to have a T-shape, and is inserted into the locking fixing groove 140c.
- the connecting protrusion 151 is formed to protrude a predetermined length toward the inner side, that is, the central side of the main body portion from the main body of the connecting wing portion, is configured to be fastened to the screw thread formed in the cover portion.
- the cover part 120 is provided at an upper portion of the main body part, and the cover part 120 is configured to close the upper end of the main body part.
- the cover part 120 includes an upper surface covering an upper end of the main body and an extension part extending downward from the upper surface and inserted into the main body, and a thread 121 is formed on an outer circumferential surface of the extension.
- the screw thread is configured such that the connecting projection of the connecting blade portion is screwed.
- a support protrusion 122 is formed between the upper surface of the cover portion and the extension portion, so that the sealing member 110c is installed between the lower portion of the upper surface and the support protrusion to stabilize the cover portion and the main body portion. It is configured to be sealed by.
- a fastening hole 123 is formed in the center of the upper surface of the cover part, and the opening and closing cap 160, which will be described later, is inserted into the fastening hole 123 to be opened and closed.
- the cover portion is formed with a protrusion 124 protruding toward the center of the fastening hole. The protrusion of the opening / closing cap to be described later is locked to the protrusion, and the opening / closing cap is configured to be opened and closed stably without being separated from the cover part when the opening / closing cap is opened or closed.
- the opening and closing cap 160 is inserted into the fastening hole 123 of the cover part.
- the opening and closing cap 160 is fastened to the cover portion to be openable.
- the opening / closing cap 160 includes an injection hole 161, locking protrusions 162a and 162b, and a sealing membrane 163.
- the injection hole 161 is formed on one side of the main body of the opening and closing cap so that the needle of the syringe for injecting blood extracted from the patient can be inserted.
- the locking protrusion is composed of an upper locking protrusion 162b and a lower locking protrusion 162a and protrudes outward from the main body of the opening / closing cap.
- the lower locking protrusion 162a comes into contact with the lower surface of the protruding portion of the cover part, and when the closing cap is closed, the upper locking protrusion 162b is upper surface of the protruding portion. Abuts against and seals between the lid and the opening / closing cap.
- the sealing membrane 163 closes the opening formed at the center of the upper surface, and is preferably formed of a material into which a syringe for extracting the multiplatelet plasma of the centrifuged blood can be easily inserted.
- the plasma extraction kit according to the present invention manufactured in a factory is sealed in a wrapping paper with the opening and closing cap open from the cover part.
- the wrapping paper is preferably made of a special paper material that one side can penetrate the disinfection gas.
- the plasma extraction kit is sterilized using a disinfection gas such as EO gas in the sealed state
- a disinfection gas such as EO gas
- the disinfection gas penetrating the packaging is injected into the plasma extraction kit through the injection hole of the opening and closing cap to facilitate disinfection. It is done.
- the wrapping paper is peeled off, and the needle of the syringe containing the blood extracted from the patient is injected through the injection hole of the opening / closing cap.
- pressing the opening and closing cap seals the lid and the opening and closing cap to complete preparation for plasma extraction.
- the plasma extraction kit is centrifuged by a centrifuge, and a plasma collection syringe is injected through the sealing membrane of the opening / closing cap. Then, the end of the needle is inserted into the center of the small diameter of the funnel to insert the PRP. It can be extracted simply.
- an opening and closing cap that can be opened and closed on the cover portion and the injection hole in the opening and closing cap, even if the plasma extraction kit is sealed with a wrapping paper in the state that the cover portion is fastened to the EO gas
- disinfecting by the disinfection gas can be introduced into the plasma extraction kit through the injection hole of the opening and closing cap can facilitate disinfection.
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- External Artificial Organs (AREA)
Abstract
Description
๋ณธ ๋ฐ๋ช ์ ํ์ฅ์ถ์ถํคํธ์ ๊ดํ ๊ฒ์ผ๋ก์, ๋์ฑ ์์ธํ๊ฒ๋ ํ์ก์ ํน์ ์ฑ๋ถ์ ๋ถ๋ฆฌ ์ถ์ถํ๊ธฐ ์ํ์ฌ ์ฌ์ฉ๋๋ ์ฅ์น๋ก์ ์ถ์ถํ๊ณ ์ ํ๋ ํน์ ์ฑ๋ถ์ ๋์ถ์จ๊ณผ ์๋๋ฅผ ๋์ด๊ณ ํ์ก์์ ํน์ ์ฑ๋ถ์ ์ถ์ถ์ด ์ฉ์ดํ ๋ฟ๋ง ์๋๋ผ, ์๋ ์ด ์ฉ์ดํ๊ณ ๊ฐํธํ ํ์ฅ์ถ์ถํคํธ์ ๊ดํ ๊ฒ์ด๋ค. The present invention relates to a plasma extraction kit, and more particularly, a device used to separate and extract a specific component of blood, to increase the concentration and purity of a specific component to be extracted and to easily extract a specific component from the blood. The present invention relates to a plasma extraction kit that is easy to disinfect and convenient.
์ผ๋ฐ์ ์ผ๋ก, ํ์ก ์์ ์๋ ํ๊ตฌ์ธํฌ๋ค์ ๋น์ค์ด ์๋ก ๋ค๋ฅธ ์ฑ๋ถ์ด ํผํฉ๋์ด ์๋ ์ํ์ธ๋ฐ, ์ด๋ฅผ ์์ฌ๋ถ๋ฆฌ ํ๊ฒ ๋๋ฉด ๊ฐ๊ฐ ์ข ๋ฅ๋ณ๋ก ์ธต์ ์ด๋ฃจ์ด ๋ชจ์ด๊ฒ ๋๋ค.In general, blood cells in the blood are mixed with different specific gravity components, when centrifuged to form a layer by each type.
์ต๊ทผ, ํ์ก์ ์๋์ผ๋ก ๋ค์ด์๋ ํ์ํ์ด ์กฐ์ง์ ์ฌ์์ ํ์ํ ํจ๊ณผ๋ฅผ ๋ฐํํ๋ค๋ ์ฌ์ค์ด ์๋ ค์ง๋ฉด์ ํดํ์ฑ ๋ณํ๋ก ์ธํด ๋ง๋ชจ๋ ์กฐ์ง์ ๊ณ ๋๋๋ก ๋์ถ๋ ํ์ํ ํ์ฅ์(PRP, Platelet Rich Plasma ํ์ํ ํ๋ถ ํ์ฅ, ์ดํ 'PRP'๋ผ ํ๋ค) ํฌ์ฌํจ์ผ๋ก์ ์กฐ์ง์ ์ฌ์ํ๋ ์น๋ฃ๋ฐฉ๋ฒ์ด ๋ง์ด ์๋๋๊ณ ์์ผ๋ฉฐ, ํผ๋ถ๋ฏธ์ฉ ๋ฐ ํผ๋ถ ์น๋ฃ์๋ ์ ์ฉ๋๋ ๋ฑ PRPํฌ์ฌ๋ ์ฌ๋ฌ ๋ถ์ผ์์ ์์ฉ๋๊ณ ์๋ ์น๋ฃ๋ฐฉ๋ฒ์ด๋ค.Recently, platelet rich plasma (PRP, Platelet Rich Plasma Platelet Rich Plasma, or 'PRP') has been known to be known for its excellent effect on tissue regeneration. PRP administration is a treatment method that is applied in many fields, such as applied to skin care and skin treatment.
ํ์ํ์ด ์ฌ์ํจ๊ณผ๋ฅผ ๋ํ๋ด๋ ์ด์ ๋ ํ์ํ ์ธํฌ ๋ด์๋ ์ฑ์ฅ์ธ์๊ฐ ํ๋ถํ๊ฒ ํจ์ ๋์ด์๊ธฐ ๋๋ฌธ์ด๋ค. ๊ณ ๋๋์ ํ์ํ์ ์น๋ฃ๋ถ์์ ์ฃผ์ ํ๊ฒ ๋๋ฉด ํ์ํ์ ์ฑ์ฅ์ธ์๋ค์ด ์ค๊ธฐ์ธํฌ๋ฅผ ํ์ฑํ์์ผ ์์๋ ์กฐ์ง์ ๋ค์ ์์ฑํ๋๋ก ํ๊ฒ ํ๋ค. PRP์ ๋์ถ์จ์ด ๋์์๋ก ์น๋ฃํจ๊ณผ๋ ์ฆ๋๋๋ค.Platelets have a regenerative effect because platelet cells contain abundant growth factors. Injecting high levels of platelets into the treatment area causes platelet growth factors to activate stem cells to regenerate damaged tissue. The higher the concentration of PRP, the greater the therapeutic effect.
์ผ๋ฐ์ ์ธ PRP ์ถ์ถ ๊ณผ์ ์ ๋จผ์ ์ธ์ฒด์์ ํ์ก์ ์ฑํํ์ฌ ์์ฌ๋ถ๋ฆฌํ๋ค. ํ์ก ์์๋ ์ฌ๋ฌ ์ธํฌ๋ค์ด ํผ์ฌ๋์ด ์๋๋ฐ ์์ฌ๋ถ๋ฆฌ๋ฅผ ํ๊ฒ ๋๋ฉด ๋์ข ์ ์ธํฌ๋ค๋ผ๋ฆฌ ๋ชจ์ด๊ฒ ๋๊ณ ๋น์ค์ ๋ฐ๋ผ ๊ฐ๊ฐ ์ธต์ ์ด๋ฃจ๊ฒ ๋๋ค. ํ์ก์ ๊ตฌ์ฑ์ ์ฉ์ก์ฑ๋ถ๊ณผ ํ๊ตฌ์ฑ๋ถ(์๊ฐฑ์ด ์ธํฌ)์ผ๋ก ๋์ด ์๋๋ฐ ํ๊ตฌ ์ฑ๋ถ์๋ ์ ํ๊ตฌ, ๋ฐฑํ๊ตฌ, ํ์ํ ๋ฐ ๊ทน์๋์ ํญ์ฒด๋ค์ด ์์ผ๋ฉฐ, ์ด๋ฌํ ํ๊ตฌ ์ธํฌ๋ค์ด 0.9%์ ์ผ๋๋ฅผ ๊ฐ์ง ์ฉ์ก ์์์ ์์ฌ์ ๋ ๋ค๋๊ณ ์๋ค. ์ด์ค ํ๊ตฌ์ฑ๋ถ์ ๋๋ถ๋ถ์ ์ฐจ์งํ๋ ๊ฒ์ ์ ํ๊ตฌ์ด๋ค.The general PRP extraction process first collects blood from the human body and centrifuges it. Several cells are mixed in the blood. When centrifuged, homogeneous cells are collected and layered according to specific gravity. The blood consists of a solution component and a blood cell component (grain cell), which contains red blood cells, white blood cells, platelets, and a very small amount of antibodies, which are mixed and floated in a solution with 0.9% salinity. Red blood cells constitute the majority of the blood cell components.
ํ์ก์ ์์ฌ๋ถ๋ฆฌํ๋ฉด 3๊ฐ ์ธต์ผ๋ก ๋ถ๋ฆฌ๊ฐ ๋๋๋ฐ ๋น์ค์ด ๊ฐ์ฅ ๋ฌด๊ฑฐ์ด ์ ํ๊ตฌ๋ค๋ ์์ฌ ๋ถ๋ฆฌ๊ด์ ์ ์ผ ํ๋ถ์ ๋ชจ์ด๊ฒ ๋๊ณ , ๊ทธ ๋ฐ๋ก ์์ธต์ ํ์ํ ๋ฐ ๋ฐฑํ๊ตฌ๋ค์ด ๋ชจ์ฌ ์์ ์ธต์ ์ด๋ฃจ๊ฒ ๋๋ฉฐ, ๊ทธ ์์ชฝ์ผ๋ก ๋๋จธ์ง ์๊ฐฑ์ด๊ฐ ๊ฑฐ์ ์๋ ์ฉ์ก ์ฑ๋ถ๋ค์ด ์์นํ๊ฒ ๋๋ค. ํ์ํ ๋ฐ ๋ฐฑํ๊ตฌ๋ค์ด ์ง์ค์ ์ผ๋ก ๋ชจ์ฌ์๋ ๊ฐ์ด๋ฐ ์์์ธต์ PRP์ด๋ผ ๋ช ๋ช ํ๋ฉฐ ๊ทธ ์์ชฝ์ ํ๊ตฌ ์๊ฐฑ์ด๊ฐ ์์ด ์ฉ์ก์ผ๋ก๋ง ์ด๋ฃจ์ด์ง ํ์ฅ์ธต์ PPP(Platelet Poor Plasma, ํ์ํ ๊ฒฐํ ํ์ฅ, ์ดํ 'PPP'๋ผ ํ๋ค)๋ผ๊ณ ๋ช ๋ช ํ๋ค.When the blood is centrifuged, it is separated into three layers. The heaviest red blood cells are collected at the bottom of the centrifuge tube, and platelets and leukocytes are gathered on the upper layer to form a thin layer. Missing solution components are placed. The platelet and leukocytes are concentrated together, and the thin layer is called PRP, and the plasma layer composed only of solution without blood cell granules above is called PPP (Platelet Poor Plasma). .
์ด์ค PRP์ธต์ ์ ๋ณ์ถ์ถํ๊ธฐ ์ํ ์ฌ๋ฌ ๊ธฐ๊ตฌ๋ค, ๋ฐฉ๋ฒ๋ค์ด ์ ์๋์๋ค.Several instruments and methods have been proposed for screening double PRP layers.
[์ ํ๊ธฐ์ ๋ฌธํ][Preceding technical literature]
(ํนํ๋ฌธํ 1) ํ๊ตญ๋ฑ๋กํนํ ์ 1016166ํธ(์๊ฐ ํ์ํ ๋์ถ๋ฌผ์ง ๋ถ๋ฆฌ๋ฐฉ๋ฒ)(Patent Document 1) Korean Registered Patent No. 1016166 (Method for separating autologous platelet concentrate)
(ํนํ๋ฌธํ 2) ํ๊ตญ๋ฑ๋กํนํ ์ 1043231ํธ(์์ฌ๋ถ๋ฆฌ๋ฐฉ๋ฒ ๋ฐ ์ด์ ์ฌ์ฉ๋๋ ์ด๋ํฐ)(Patent Document 2) Korean Registered Patent No. 1043231 (centrifugal separation method and adapter used therein)
(ํนํ๋ฌธํ 3) ํ๊ตญ๋ฑ๋กํนํ ์ 1029255ํธ(์์ฌ๋ถ๋ฆฌ์ฅ์น)(Patent Document 3) Korean Registered Patent No. 1029255 (centrifugal separator)
๊ทธ๋ฌ๋, ์ข ๋์ PRP์ถ์ถ๋ฐฉ๋ฒ์ ์ํ๋ฉด, ์๋ ๋์ PRP์ถ์ถ์ด ๊ทธ๋ฆฌ ์ฉ์ดํ์ง ์๋ค๋ ๋ฌธ์ ์ ์ด ์์๋ค. However, according to the conventional PRP extraction method, there is a problem that high purity PRP extraction is not easy.
์ฆ, ํฌํจ๋์ง ์์์ผ ํ ์ ํ๊ตฌ๊ฐ ํฌํจ๋์ด ์ถ์ถ๋๋ ๋ฌธ์ ๊ฐ ์๊ณ , ์ถ์ถํ๋ ๊ณผ์ ์ด ๋งค์ฐ ์ ๋ฐํ์ฌ ์ถ์ถ์์ ๋ฐ๋ผ์ PRP์ ๋๋๊ฐ ์ผ์ ํ์ง ์์ ์ ๋ ๊ด๋ฆฌ์์ ํธ์ฐจ๊ฐ ์์ผ๋ฉฐ, ์ถ์ถ๊ณผ์ ์ด ์ฌ์ธํ ์กฐ์์ ํ์ํ๋ค ๋ณด๋ ์๊ฐ์ด ๋ง์ด ์๋ชจ๋๊ณ , ์ถ์ถ๋ PRP์ ๋์ถ์จ์ ํ์์ ๋ฐ๋ผ ๊ณ ๋๋์์ ์ ๋๋๊น์ง ์์ ๋กญ๊ฒ ์กฐ์ ํ๊ธฐ ์ด๋ ค์ด ๋ฌธ์ ๊ฐ ์์ผ๋ฉฐ, ๊ธฐ์กด์ PRP ์ถ์ถ์ฉ ์์ฌ๋ถ๋ฆฌ๊ด์ ๊ฐ๊ฒฉ์ด ๋งค์ฐ ๊ณ ๊ฐ์ธ ๋ฌธ์ ๋ค์ด ์๋ค.That is, there is a problem that red blood cells are included, which should not be included, and the extraction process is very precise, so that the concentration of PRP is not constant according to the extractor, resulting in deviations in the degree of control, and the extraction process requires delicate manipulation. It takes a lot of time, there is a problem that it is difficult to freely control the concentration of the extracted PRP from high concentration to low concentration, there is a problem that the price of the conventional PRP extraction centrifuge tube is very expensive.
ํ์ก์ ์์ฌ๋ถ๋ฆฌ ํ๋ฉด, PRP๋ ์์ฃผ ์์ ๋๊ป๋ฅผ ๊ฐ์ง ์ธต์ผ๋ก ๋ํ๋๋ฉฐ, ๋ฐ๋ก ์๋์ ์ ํ๊ตฌ ์ธต ์ ์ฒด์ ์๊ณ ๋๊ฒ ๋ํฌ๋์ด ์๋ ๋ชจ์ต์ผ๋ก ๋ณด์ด๊ฒ ๋๊ณ , ์ ์ผ ํ๋ถ์ ๋ชจ์ด๊ฒ ๋๋ ์ ํ๊ตฌ์ธต์ ๋๊ป๋ ์ฌ๋์ ๋ฐ๋ผ ๋ค๋ฅธ๋ฐ, ์ ํ๊ตฌ๊ฐ ํ์ก ์ ์ฒด์ ์ฉ์ ์์ ์ฐจ์งํ๋ ๋น์จ์ด ์ ๊ฒ๋ 25%์์ ๋ง๊ฒ๋ 50%๊น์ง ๋์ ํธ์ฐจ๋ฅผ ๋ณด์ด๊ณ ์๊ธฐ ๋๋ฌธ์, ์๋๋์ PRP๋ฅผ ์ถ์ถํ๊ธฐ๊ฐ ์ฉ์ดํ์ง ์๊ฒ ๋๋ค.When the blood is centrifuged, the PRP appears as a very thin layer, which appears to be thin and widely spread over the entire red blood cell layer directly below, and the thickness of the red blood cell that is collected at the bottom is different depending on the person. Since the ratio of the total volume of the whole blood varies from as little as 25% to as much as 50%, it is not easy to extract high purity PRP.
์ ํ๊ตฌ์ธต ์ต์๋จ ์์ ์๊ฒ ํผ์ ธ์๋ PRP๋ฅผ ์ถ์ถํ๊ธฐ ์ํด์๋ ์ํ๊ด ์์ผ๋ก ๋๋ค์ ๋ฃ๊ณ ๋๋ค์ ๋๋ถ๋ถ์ PRP์ธต์ ๋ฟ๊ฒ ํ์ฌ ํก์ ํ๋ ๋ฐฉ์์ผ๋ก ์ถ์ถํ๊ฒ ๋๋๋ฐ ์ด๋ ์ ํ๊ตฌ์ธต์ ์๋จ๋ถ์๋ฅผ ๊ธ์ด๊ฐ๋ฉฐ ์ถ์ถํ ์ ๋ฐ์ ์๋ค. ์ด ๊ณผ์ ์์ ์ ์ง ์์ ์ ํ๊ตฌ๋ค์ด PRP์ ํจ๊ป ๋นจ๋ ค ๋ค์ด์ค๊ฒ ๋๊ณ , ์ด ์ ํ๊ตฌ๋ค์ ํ์์๊ฒ ์์ ํ ๋ PRP์ ํจ๊ป ์กฐ์ง์ ์ฃผ์ ๋๊ฒ ๋๋ค. In order to extract PRP thinly spread on the top of the erythrocyte layer, the needle is inserted into the test tube, and the tip of the needle touches the PRP layer and is extracted by inhaling it. In the process, a significant number of red blood cells are sucked in with the PRP, and these red blood cells are injected into the tissue along with the PRP when the patient is treated.
PRP์ ๋นจ๋ ค ๋ค์ด์จ ์ ํ๊ตฌ๋ค์ ๋ ๊ฐ์ง ๋ฌธ์ ๋ฅผ ์ผ๊ธฐํ๋๋ฐ ์ฒซ ๋ฒ์งธ๋ ๊ทธ ์ ํ๊ตฌ ์์ด ๋ง์์๋ก PRP์ ๋์ถ์จ์ด ์ ํ๋์ด ์น๋ฃํจ๊ณผ๋ฅผ ๋จ์ด๋จ๋ฆฌ๊ฒ ๋๋ฉฐ, ๋ ๋ฒ์งธ๋ ์์ ํ ํ์๋ค์ด ์์ ๋ถ์์ ๊ฒฉ์ฌํ ํต์ฆ์ ํธ์ํ๋ ์์ธ์ด ๋๋ค. ์์ํ PRP๋ฅผ ์ฃผ์ ํด๋ ์น๋ฃ ํ์ ํต์ฆ์ด ์ด๋ ์ ๋ ๋๋ฐ๋๋๋ฐ ์งง๊ฒ๋ 1์ผ, ๊ธธ๊ฒ๋ 1์ฃผ์ผ๊น์ง๋ ์ง์ ๋๋ฉฐ ์ฌํ ๊ฒฝ์ฐ ๋ง์ฝ์ฑ ์งํต์ ๋ฅผ ํฌ์ฌํด์ผ ํ๋ ๊ฒฝ์ฐ๋ ์๋ค. ์ด๋ ์ ํ๊ตฌ๋ค์ด ๊ฐ์ด ์ฃผ์ ๋๊ฒ ๋๋ฉด ํต์ฆ์ ๋์ฑ ์ฌํด์ง๊ฒ ๋๋ค. ์ด๋ฌํ ์ด์ ๋ก PRP ์ถ์ถ์ ๊ฐ๋ฅํ ํ ์ ํ๊ตฌ๊ฐ ํฌํจ๋์ง ์๋๋ก ํ๊ธฐ ์ํด ์ฌ๋ฌ ๋ฐฉ๋ฒ๋ค์ ๋์ํ๊ณ ์๋๋ฐ ๊ฐ์ฅ ์ผ๋ฐ์ ์ผ๋ก ์ฐ์ด๋ ๋ฐฉ๋ฒ์ด PRP์ธต์ด ํ์ฑ๋ ๊ฒ์ผ๋ก ์์ธก๋๋ ๋ถ๋ถ์ ์์ฌ๋ถ๋ฆฌ๊ด ์ง๊ฒฝ์ ์๊ฒ ๋ง๋ค์ด ์ค์ด๋ ๋จ๋ฉด์ ์ ๋น๋กํ์ฌ PRP๊ฐ ๋๊ป๊ฒ ์์ด๊ฒ ํ์ฌ ์ ํ๊ตฌ์ธต๊ณผ ์ ์ดํ๋ ๋ฉด์ ์ ์ค์ธ ๋ค ์ถ์ถํ๋ ๋ฐฉ์์ ํํ๊ณ ์๋ค. ์ด๋ฌํ ๋ฐฉ๋ฒ์ ์ฌ์ฉํ ๋ ํ๊ฐ์ง ๋ฌธ์ ์ ์ด ์๋๋ฐ, ์๋ก ๋ค๋ฅธ ์ฌ๋์๊ฒ์ ๋์ผํ ์์ ํ์ก์ ์ฑํํ์ฌ ์์ฌ๊ด์ ๋ฃ์ด ์์ฌ๋ถ๋ฆฌ ํ๋๋ผ๋ ์์ ํ ๋ฐ์ ๊ฐ์ด ์ ํ๊ตฌ์ ์์ด ์ฌ๋๋ง๋ค ๋ค๋ฆ์ผ๋ก ์ธํด ํ๋ถ ์ ํ๊ตฌ์ธต์ ๋๊ป๊ฐ ๋ค๋ฅด๊ฒ ๋ํ๋๋ค. ๋ฐ๋ผ์ PRP๊ฐ ํ์ฑ๋ ๊ฒ์ผ๋ก ์์ธกํ ๋ถ์์ ์์ฌ๋ถ๋ฆฌ ํ PRP๊ฐ ์ค์ ๋ก ์์นํ๊ฒ ๋๋ ๊ฒฝ์ฐ๋ ๊ฑฐ์ ์๋ค.Erythrocytes sucked into PRP cause two problems. First, the higher the amount of red blood cells, the lower the concentration of PRP, which lowers the therapeutic effect. Second, the patients complain of severe pain after the procedure. Cause. Even with pure PRP, there is some pain after treatment, which lasts as long as 1 day and as long as 1 week. In some cases, narcotic analgesics may be required. When the red blood cells are injected together, the pain becomes more severe. For this reason, several methods are used to prevent the inclusion of red blood cells in PRP extraction. The most commonly used method is to reduce the diameter of the centrifuge tube in the area where the PRP layer is expected to form and to reduce the proportion of PRP. By stacking thicker to reduce the area in contact with the erythrocyte layer is taking a way to extract. When using this method, there is one problem. Even when the same amount of blood is collected from different people and centrifuged into a centrifuge tube, the thickness of the lower red blood cell layer is different due to the different amount of red blood cells as described above. Therefore, the PRP is rarely actually located after centrifugation at the site where the PRP is expected to form.
๊ทธ๋์ ๋ถ๋ฆฌ์ฅ์น ํ๋ถ์ ์ ํ๊ตฌ์ธต์ ๋์ด๋ฅผ ์กฐ์ ํ์ฌ PRP๋ฅผ ์ง๊ฒฝ์ด ์ข์ ๋ฅ๋ถ์์ ์์นํ๋๋ก ํด์ฃผ๋ ๋ณด์ ์ฅ์น๊ฐ ์๋ฐ๋์ด์ผ ํ๋๋ฐ ํต์ ์์ฌ๋ถ๋ฆฌ๊ด์ ํ๋ถ์ ๋์ฌ ํํ๋ก ๋์ด์๋ ๋ง๊ฐ๋ฅผ ์ํฉ์ ๋ฐ๋ผ ์ ๊ธ ๋ฐฉํฅ์ด๋ ํธ๋ ๋ฐฉํฅ์ผ๋ก ๋๋ฆฌ๋ฉด์ ์ ํ๊ตฌ์ธต์ ๋๋ฎ์ด๋ฅผ ์กฐ์ ํ๊ฒ ๋๋ค. ๊ทธ๋ฐ๋ฐ ์ด๋ฌํ ๋ฐฉ์์ ์์ฌ๋ถ๋ฆฌ๊ด์ 3000-4000RPM์ ๊ณ ์ํ์ ์ ์์ฌ๊ด ํ๋ถ์๋ ํ์ก์ ์์ฒญ๋ ํ์ถ ์๋ ฅ์ด ๊ฑธ๋ฆฌ๊ฒ ๋์ด ๋์ฌ๋ถ์๋ฅผ ํตํ์ฌ ํ์ก์ด ํ๋ฌ๋์ฌ ์ ์๋ ๊ฐ๋ฅ์ฑ์ด ์๋ค. ์ด๋๋ฌธ์ ๋์ก ๋ฐฉ์ง๋ฅผ ์ํ ์ถ๊ฐ ๋ถํ๋ค๊ณผ ์ ๋ฐํ ๊ตฌ์กฐ ์ ์์ด ํ์ํ๊ฒ ๋๊ณ ์ด๋ ์ ์๋จ๊ฐ ์์น์ผ๋ก ์ด์ด์ ธ ์์ฌ๋ถ๋ฆฌ๊ด์ ๊ฐ๊ฒฉ์ด ๊ณ ๊ฐ๊ฐ ๋ ์๋ฐ์ ์์ผ๋ฉฐ ๊ฒฐ๊ณผ์ ์ผ๋ก ์ต์ข ์น๋ฃ๊ธ์ก๋ ๋์์ง๊ฒ ๋๋ค. ๊ทธ๋ฆฌ๊ณ ์ด๋ ๊ฒ ๊ณ ์๋ ์ถ์ถ ์ฅ์น๋ค๋ ์ค์ ์์์์ ์ฌ์ฉํด ๋ณด๋ฉด ๋ฅ ๋ถ๋ถ์ ๊ธธ์ด๊ฐ ์งง์์ PRP๋ฅผ ์ด ๋ถ๋ถ์ ์ ํํ ์์นํ๊ฒ ํ๋ ๊ฒ์ด ์๋นํ ์ด๋ ค์ฐ๋ฉฐ ํ๋ถ์ ๋์ฌ์ฅ์น๋ฅผ ๋๋ ค ์ธต์ ์ด๋ํ๋ ๊ณผ์ ์์ PRP์ธต์ด ์ด๋ ์ ๋ ํฉ์ด์ ธ ๋ฒ๋ฆฌ๋ ๊ฒฐ๊ณผ๋ฅผ ์ด๋ํ๋ค.Therefore, a correction device that adjusts the height of the red blood cell layer in the lower part of the separator to position the PRP in the narrow neck portion should be accompanied. Usually, a screw-shaped stopper in the lower part of the centrifuge tube may be locked or released depending on the situation. Rotating in the direction to control the height of the red blood cell layer. By the way, the centrifuge tube of this type has a great escape pressure of blood in the lower part of the centrifuge tube during the high-speed rotation of 3000-4000RPM, and there is a possibility that blood can flow out through the screw part. For this reason, it is necessary to manufacture additional parts and precise structure to prevent leakage, which leads to an increase in manufacturing cost, which inevitably increases the price of the centrifuge tube, resulting in a higher final treatment amount. And the extraction devices designed like this have a short neck length so that it is very difficult to accurately place the PRP in this part.The result is that the PRP layer is scattered to some extent in the process of moving the layer by rotating the lower screw device. Results in.
๋ํ, PRP๋ฅผ ์ถ์ถํ๋ ์ข ๋์ ๋ฐฉ๋ฒ์ผ๋ก๋, ํ๊ตญ์ค์ฉ์ ์๋ฑ๋ก 20-0273082ํธ์ ๊ธฐ์ฌ๋ ๋ฐ์ ๊ฐ์ด, ํ์ฒญ๋ถ๋ฆฌ์ฉ ์ฃผ์ฌ๊ธฐ๋ฅผ ์ฌ์ฉํ๋ ๋ฐฉ๋ฒ์ด ๊ฐ์๋์ด ์๋ค. In addition, as a conventional method of extracting PRP, a method of using a syringe for serum separation is disclosed, as described in Korean Utility Model Registration No. 20-0273082.
์๊ธฐ ์ข ๋๊ธฐ์ ์ ์ํ๋ฉด, ์๋ถ๋ก ํผ์คํค์ด ์ด๋ ๊ฐ๋ฅํ๊ฒ ์ฝ์ ๋๋ฉฐ, ํ๋ถ์๋ ์ฃผ์ฌ๋ฐ๋์ด ๊ณ ์ ๋๋ ๋ฐ๋์ฐ๊ฒฐ๊ตฌ๊ฐ ํ์ฑ๋๊ณ , ๋ด๋ถ์๋ ํ์ก๊ณผ ํ์ฒญ์ ๋ถ๋ฆฌํ๋ ํ์ฒญ๋ถ๋ฆฌ์ฉ ๊ฒ์ด ์ผ์ ๋ ์ถฉ์ง๋๋ ์ค๋ฆฐ๋์; ์ค๋ฆฐ๋์ ํ๋ถ์ ํ์ฑ๋๋ ๋ฐ๋์ฐ๊ฒฐ๊ตฌ ์๋ถ๋ก ๋์ถ ๋๋ฉด์ ์ค๋ฆฐ๋์ ๋ด๋ถ์ ํ์ฑ๋์ด ์ฃผ์ฌ๊ธฐ์ ๋ด๋ถ์ ์ถฉ์ง๋๋ ํ์ฒญ๋ถ๋ฆฌ์ฉ ๊ฒ์ด ์ฃผ์ฌ๋ฐ๋์ด ๊ณ ์ ๋๋ ๋ฐ๋์ฐ๊ฒฐ๊ตฌ ์ชฝ์ผ๋ก ๋ฐฐ์ถ๋์ง ์๋๋ก ํ๋ ๋์ถ๋ถ์; ์ฃผ์ฌ๋ฐ๋์ด ๊ณ ์ ๋๋ ์ค๋ฆฐ๋์ ๋ฐ๋์ฐ๊ฒฐ๊ตฌ์์ ์ฃผ์ฌ๋ฐ๋์ด ์ ๊ฑฐ๋ ๋ ๋ฐ๋์ฐ๊ฒฐ๊ตฌ์ ํ๋ถ์ ๊ณ ์ ๋๋ฉฐ, ๋ฐ๋์ฐ๊ฒฐ๊ตฌ๋ฅผ ๋ฐํ์ํค๋ ๋ฐํ๊ตฌ๊ฐ ์๋ถ๋ก ๋์ถ๋๊ฒ ํ์ฑ๋๋ ํ๋ถ๋ง๊ฐ์; ์ค๋ฆฐ๋์ ์ด๋ ๊ฐ๋ฅํ๊ฒ ๊ณ ์ ๋๋ ํผ์คํค์ด ์ ๊ฑฐ๋ ๋ ์ค๋ฆฐ๋์ ๊ฐ๊ตฌ๋ ์๋ถ์ ๊ณ ์ ๋๋ฉฐ, ์ค๋ฆฐ๋์ ๋ฐ์ฐฉ๋๋ ๋ฉด์ ๋ค์๊ฐ์ ๋ฐ์ฐฉ๊ตฌ๊ฐ ํ์ฑ๋๋ ์๋ถ๋ง๊ฐ๋ฅผ ํฌํจํ์ฌ ์ด๋ฃจ์ด์ง๋ ํ์ฒญ๋ถ๋ฆฌ์ฉ์ฃผ์ฌ๊ธฐ๊ฐ ๊ฐ์๋์ด ์๋ค. According to the prior art, a piston is inserted into the upper part to be movable, the lower portion is formed with a needle connector is fixed to the needle, the inside is filled with a certain amount of serum separation gel for separating blood and serum therein; A protrusion which protrudes above the needle connector formed in the lower portion of the cylinder and is formed inside the cylinder so that the serum separation gel filled in the syringe is not discharged toward the needle connector where the needle is fixed; A lower stopper which is fixed to the lower part of the needle connector when the needle is removed from the needle connector of the cylinder to which the needle is fixed, and a seal which seals the needle connector protrudes upward; When the piston movably fixed to the cylinder is removed is fixed to the open top of the cylinder, a serum separation syringe comprising an upper stopper is formed on the surface in close contact with the cylinder is formed.
์๊ธฐ ์ข ๋๊ธฐ์ ์ ์ํ๋ฉด, ํ์ก์ ์ค๋ฆฐ๋์ ์ผ์ ๋ ์ฃผ์ ํ ํ, ์๋ถ๋ง๊ฐ์ ์ํด ์ค๋ฆฐ๋๋ฅผ ๋ฐ๋ด์ํค๋ ๊ตฌ์กฐ๋ฅผ ๊ฐ๋๋ค. According to the prior art, after a certain amount of blood is injected into the cylinder, the cylinder is sealed by an upper cap.
ํํธ, ํ์ก๋ถ๋ฆฌ์ฉ ์ฃผ์ฌ๊ธฐ๋ ํ์ฅ์ถ์ถํคํธ ๋ฐ ํ์ก์ถ์ถ์ ์ฌ์ฉ๋๋ ์ฃผ์ฌ๊ธฐ ๋ฑ ์๋ฃ๊ธฐ๊ธฐ๋ ์ถ์ถ๋ ํ์ก์ ๊ท ์ด ์นจํฌํ์ง ์๋๋ก ๋ฌด๊ท ๋ฐ ๋ฉธ๊ท ์ฒ๋ฆฌ๋ ๋ฌผ๋ก ๋ฐ๋ด์ฑ์ด ๋งค์ฐ ์ค์ํ ์์์ด๋ค. On the other hand, medical devices such as blood separation syringes, plasma extraction kits and syringes used for blood extraction are very important factors as well as sterilization and sterilization so that bacteria do not penetrate the extracted blood.
์ด๋ฌํ ์๋ฃ๊ธฐ๊ธฐ ๋ฑ์ ์๋ ๋ฐฉ๋ฒ์ผ๋ก๋, ๊ณ ์จ์ ์คํ์ ์ํด ๋ฉธ๊ท ํ๋ ๋ฐฉ๋ฒ๊ณผ, EO๊ฐ์ค๋ฅผ ํฌ์ ํ์ฌ ๋ฉธ๊ท ํ๋ ๋ฐฉ๋ฒ๊ณผ, ๊ฐ๋ง์ ์ ์กฐ์ฌํ์ฌ ๋ฉธ๊ท ํ๋ ๋ฐฉ๋ฒ์ด ์ฃผ๋ก ์ฌ์ฉ๋๊ณ ์๋ค. ๊ณ ์จ์ ์คํ์ ์ํด ๋ฉธ๊ท ํ๋ ๋ฐฉ๋ฒ์ ๊ฒฝ์ฐ, ํ๋ผ์คํฑ ์ ํ ๋ฑ์ ์ ์ฉํ๊ธฐ ๊ณค๋ํ๋ค๋ ๋ฌธ์ ์ ์ด ์์ ๋ฟ๋ง ์๋๋ผ ๋ฐ๋ด์ํ์์ ๋ฉธ๊ท ํ๊ธฐ ์ด๋ ต๋ค๊ณ ํ๋ ๋ฌธ์ ์ ์ด ์์ผ๋ฉฐ, EO๊ฐ์ค๋ฅผ ํฌ์ ํ์ฌ ๋ฉธ๊ท ํ๋ ๋ฐฉ๋ฒ๋ ์๋ฃ๊ธฐ๊ธฐ๊ฐ ๊ณต์ฅ์์ ๋ฐํ๋ ์ํ๋ก ์ถ์๋๋ฏ๋ก ์๋ฃ๊ธฐ๊ธฐ ๋ด๋ถ๋ฅผ ์๋ ํ๊ธฐ ์ด๋ ค์ฐ๋ฉฐ, ๊ฐ๋ง์ ์ ์กฐ์ฌํ๋ ๋ฉธ๊ท ๋ฐฉ์๋ ํ๋ผ์คํฑ ์ ํ์ ์ ์ฉํ ์๋ ์์ผ๋ ๊ฐ๋ง์ ์ ๊ฒฌ๋๊ฒ ํ๊ธฐ ์ํ์ฌ ํน์ ์ฒ๋ฆฌ๋ฅผ ํ์ฌ์ผ ํ๋ฏ๋ก, ํ๋ผ์คํฑ ์ ํ์ ์ ์ฉํ๊ธฐ ์ด๋ ต๊ณ ์ ์กฐ๋น์ฉ์ด ๊ณ ๊ฐ๋ก ๋๋ค๊ณ ํ๋ ๋ฌธ์ ์ ์ด ์์๋ค. As a disinfection method of such a medical device, a method of sterilization by high temperature steam, a method of sterilizing by adding EO gas, and a method of sterilizing by irradiating gamma rays are mainly used. In the case of sterilization by high temperature steam, not only is it difficult to apply to plastic products, but also has a problem of being difficult to sterilize in a sealed state. It is difficult to disinfect the inside of medical devices because it is released in the state, and the sterilization method that irradiates gamma rays can be applied to plastic products, but it is difficult to apply to plastic products and the manufacturing cost becomes expensive because special treatment must be performed to endure gamma rays. There was a problem.
๋ณธ ๋ฐ๋ช ์ ์์ ํ ์ข ๋๊ธฐ์ ์ ๋ฌธ์ ์ ์ ํด๊ฒฐํ๊ณ ์ ํ๋ ๊ฒ์ผ๋ก์, ๋ณธ ๋ฐ๋ช ์ ๋ชฉ์ ์ ๊ณต์ฅ์์ ์ ์กฐ๋๋ ์ฃผ์ฌ๊ธฐ๋ ํ์ฅ์ถ์ถํคํธ๊ฐ ๋ฐ๋ด๋ ์ํ์์ ์๋ ์ด ๊ฐ๋ฅํ ๋ฟ๋ง ์๋๋ผ, ํ์๋ก๋ถํฐ ์ถ์ถํ ํ์ก์ ํคํธ์ ์ฃผ์ ํ ๋์ ์ค์ผ์ ์ผ๋ ค๊ฐ ์ ๊ณ ์ฃผ์ ๋ฐ ๋ฐ๋ด์ด ์ฉ์ดํ ํ์ฅ์ถ์ถํคํธ๋ฅผ ์ ๊ณตํ๋ ๊ฒ์ด๋ค. The present invention is to solve the above-mentioned problems of the prior art, an object of the present invention is not only capable of disinfection in a sealed syringe or plasma extraction kit manufactured at the factory, but also when injecting the blood extracted from the patient into the kit It is to provide a plasma extraction kit that is less concerned about contamination and easy to inject and seal.
๋ํ, ๋ณธ ๋ฐ๋ช ์ ๋ค๋ฅธ ๋ชฉ์ ์ ์ถ์ถ๋ PRP๊ฐ ์๋์ฑ๊ณผ ๋์ถ์จ์ ์ฆ๊ฐ๋๊ณ , ์ถ์ถ ์กฐ์์ ์ฉ์ด์ฑ์ ๋ ๊ฐ์ ๋๋ฉฐ, ์ ์๋จ๊ฐ๋ ๊ฒฝ๊ฐ๋ ์ ์๋ ํ์ฅ์ถ์ถํคํธ๋ฅผ ์ ๊ณตํ๋ ๊ฒ์ด๋ค. In addition, another object of the present invention is to provide a plasma extraction kit in which the extracted PRP is increased in purity and concentration, the ease of extraction operation is further improved, and the manufacturing cost can be reduced.
์์ ํ ๋ชฉ์ ์ ๋ฌ์ฑํ๊ธฐ ์ํ์ฌ, ๋ณธ ๋ฐ๋ช ์ ์ํ ํ์ฅ์ถ์ถํคํธ๋, ์๋จ์ด ๊ฐ๊ตฌ๋๊ณ ํ๋จ์ด ํ์๋์ด ์๋ ์ํตํ ํ์์ ๋ณธ์ฒด๋ถ์, ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ ์ค์๋ถ๋ถ์ ์ฒด๊ฒฐ๋๋ฉฐ, ์ค์๋ถ์ ์ง๊ฒฝ์ด ์๊ณ ์๋จ๋ถ๋ ์ค์๋ถ๋ฅผ ํฅํ์ฌ ์ง๊ฒฝ์ด ์ ์ฐจ ๊ฐ์ํ๋ ํ ์ดํผ ํ์์ผ๋ก ํ์ฑ๋ ๊น๋๊ธฐ๋ถ์, ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๋จ์ ํ์ํ๋ ๋ฎ๊ฐ๋ถ๋ฅผ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. In order to achieve the above object, the plasma extraction kit according to the present invention, the upper end is opened and the lower end is closed with a cylindrical body portion, and fastened to the inner central portion of the main body portion, the diameter of the central portion is small and both ends It characterized in that it comprises a funnel portion formed in a tapered shape that gradually decreases in diameter toward the central portion, and a cover portion for closing the upper end of the main body portion.
๋ํ, ๋ณธ ๋ฐ๋ช ์ ํ์ก์ผ๋ก๋ถํฐ ํ์ฅ ์ฑ๋ถ์ ์ถ์ถํ๋ ํ์ฅ ์ถ์ถ ํคํธ์ ์ํด ์ฃผ์ ๋ ํ์ก์ 1์ฐจ๋ก ์์ฌ๋ถ๋ฆฌํ ํ ์์ฌ๋ถ๋ฆฌ๋ ํ์ก์ PPP์ ์ ํ๊ตฌ๋ก๋ถํฐ 2์ฐจ ์์ฌ๋ถ๋ฆฌ์ ์ํด ํ์ฅ์ ๋์ฑ ์ถ์ถํ๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ํฌํจํ์ฌ ๊ตฌ์ฑ๋๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. In addition, the present invention is the second centrifugal to further extract the plasma by the second centrifugation from the PPP and erythrocytes of the centrifuged blood after the first centrifugation of the blood injected by the plasma extraction kit for extracting the plasma components from the blood Characterized in that comprises a separator tube.
์์ ํ ๊ตฌ์ฑ์ ๊ฐ์ง๋ ๋ณธ ๋ฐ๋ช ์ ์ํ๋ฉด, ์๋ ๋์ ๊ณ ๋๋์ PRP๋ฅผ ์ฉ์ดํ๊ฒ ์ถ์ถํ ์ ์๊ณ , ์ถ์ถ ๊ณผ์ ์์ ์ ํ๊ตฌ๋ฅผ ๊ฑฐ์ ๋ฐฐ์ ํ๊ณ ์ถ์ถํ ์ ์์ผ๋ฉฐ, ์กฐ์์์ ๋ฐ๋ฅธ ์ ๋ ํธ์ฐจ๊ฐ ์ ๊ณ ์ถ์ถ์๊ฐ์ ๋จ์ถํ ์ ์์ผ๋ฉฐ, ์์ฌ๋ถ๋ฆฌ๊ด์ ์ ์๋จ๊ฐ๋ฅผ ๋ฎ์ถ์ด ์์ ์๋ค์ ์น๋ฃ๋น์ฉ์ ๊ฒฝ๊ฐ์ํฌ ์ ์๋ ์ฅ์ ์ด ์๋ค. ์์ฌ๋ถ๋ฆฌํ์ ํ์ก์ฑ๋ถ ์ค ๋ค๋์ธ ์ ํ๊ตฌ๋ ํ์ก์ ์ฅ๋ถ์ ์์ฉ๋๊ณ , ์๋์ธ PRP๋ ์ง๊ฒฝ์ด ์์ ๊น๋๊ธฐ๋ถ์ ์ค์์ ์์ฉํ ์ ์์ผ๋ฏ๋ก, ์๋์ธ PRP์ ์ถ์ถ์ ์ฉ์ดํ๊ฒ ํ ์ ์๋ค. According to the present invention having the above-described configuration, it is possible to easily extract a high-purity high concentration of PRP, can be extracted by almost eliminating red blood cells in the extraction process, the degree of variation is small according to the operator and the extraction time can be shortened By lowering the manufacturing cost of the centrifuge tube, there is an advantage that can reduce the treatment cost of the operators. After centrifugation, a large amount of red blood cells in the blood component is accommodated in the blood storage unit, and a small amount of PRP can be accommodated in the center of the funnel having a small diameter, thereby facilitating extraction of a small amount of PRP.
๋ํ, ์ฌ๋์ ๋ฐ๋ผ ์ ํ๊ตฌ์ ์์ด ๋ค๋ฅด๋ค ํ๋๋ผ๋ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์์น๋ฅผ ์กฐ์ ํ ์ ์์ผ๋ฏ๋ก, ์๊ธฐ ๊น๋๊ธฐ๋ถ์ PRP๋ฅผ ์ ํํ๊ฒ ์์น์ํฌ ์ ์๊ณ , ์ด๋ก์จ ์๋ ๋์ ๊ณ ๋๋์ PRP๋ฅผ ์ฉ์ดํ๊ฒ ์ถ์ถํ ์ ์๊ณ , ์ถ์ถ ๊ณผ์ ์์ ์ ํ๊ตฌ๋ฅผ ๊ฑฐ์ ๋ฐฐ์ ํ๊ณ ์ถ์ถํ ์ ์์ผ๋ฉฐ, ์กฐ์์์ ๋ฐ๋ฅธ ์ ๋ ํธ์ฐจ๊ฐ ์ ๊ณ ์ถ์ถ์๊ฐ์ ๋จ์ถํ ์ ์์ผ๋ฉฐ, ์์ฌ๋ถ๋ฆฌ๊ด์ ์ ์๋จ๊ฐ๋ฅผ ๋ฎ์ถ์ด ์์ ์๋ค์ ์น๋ฃ๋น์ฉ์ ๊ฒฝ๊ฐ์ํฌ ์ ์๋ ์ฅ์ ์ด ์๋ค.In addition, even if the amount of red blood cells differs from person to person, since the position of the funnel can be adjusted, the PRP can be accurately positioned in the funnel, thereby easily extracting high-purity PRP with high purity and red blood cells in the extraction process. The extraction can be almost excluded, and the degree of variation according to the operator is small, the extraction time can be shortened, and the manufacturing cost of the centrifuge tube can be lowered to reduce the treatment cost of the operators.
๋ 1์ ์ข ๋๊ธฐ์ ์ ํ์ฅ์ถ์ถํคํธ๋ฅผ ๋ํ๋ด๋ ๋๋ฉด, 1 is a view showing a plasma extraction kit of the prior art,
๋ 2๋ ๋ณธ ๋ฐ๋ช ์ ์ 1 ์ค์์์ ์ํ ํ์ฅ ์ถ์ถ ํคํธ๋ฅผ ๋ํ๋ด๋ ๋๋ฉด,2 is a view showing a plasma extraction kit according to a first embodiment of the present invention,
๋ 3์ ์ 1 ์ค์์์ ํ์ฅ์ถ์ถํคํธ์ ์ฌ์๋ ๋ฐ ๋จ๋ฉด๋,3 is a perspective view and a cross-sectional view of the plasma extraction kit of the first embodiment,
๋ 4๋ ์ 1 ์ค์์์ ํ์ฅ์ถ์ถํคํธ์ ๋ด๋ถ์ ์ฝ์ ํ๋ ๊น๋๊ธฐ๋ถ์ ์ฌ์๋ ๋ฐ ๋จ๋ฉด๋,4 is a perspective view and a cross-sectional view of the funnel to be inserted into the plasma extraction kit of the first embodiment,
๋ 5๋ 1์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ๋ํ๋๋ ํ์ก์ธต์ ๋จ๋ฉด๋,5 is a cross-sectional view of the blood layer after the first centrifugation,
๋ 6์ 1์ฐจ PRP ๋ฐ PPP ์ถ์ถํ๋ ๋ชจ์ต์ ๋ณด์ฌ์ฃผ๋ ๋จ๋ฉด๋,6 is a cross-sectional view showing the first PRP and PPP extraction;
๋ 7์ 1์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ์ ํ๊ตฌ ๊ณผ๋ค ํ์ก์ ๋ชจ์ต์ ๋ณด์ฌ์ฃผ๋ ๋จ๋ฉด๋, 7 is a cross-sectional view showing the appearance of excess red blood cells after the first centrifugation;
๋ 8์ 1์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ์ ํ๊ตฌ ๊ณผ์ ํ์ก์ ๋ชจ์ต์ ๋ณด์ฌ์ฃผ๋ ๋จ๋ฉด๋, Figure 8 is a cross-sectional view showing the appearance of red blood cells under the first centrifugation,
๋ 9๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ์ฌ์๋ ๋ฐ ๋จ๋ฉด๋,9 is a perspective view and a cross-sectional view of the secondary centrifuge tube,
๋ 10์ 2์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ๋ํ๋๋ ํ์ก์ธต์ ๋จ๋ฉด๋,10 is a cross-sectional view of the blood layer after secondary centrifugation,
๋ 11์ ์์ธต์ PPP๋ฅผ ์ถ์ถํ๋ ๋ชจ์ต์ ๋ณด์ฌ์ฃผ๋ ๋จ๋ฉด๋,11 is a cross-sectional view showing the extraction of the PPP of the upper layer,
๋ 12๋ ๋จ์ ์๋์ PPP, PRP, ์๋์ ์ ํ๊ตฌ๋ฅผ ๋ณด์ฌ์ฃผ๋ ๋จ๋ฉด๋,12 is a cross-sectional view showing a small amount of remaining PPP, PRP, small amount of red blood cells,
๋ 13์ ์ต์ข ์ ์ธ PRP๋ฅผ ์ถ์ถํ๋ ๋ชจ์ต์ ๋ณด์ฌ์ฃผ๋ ๋จ๋ฉด๋, 13 is a cross-sectional view showing a state of extracting the final PRP,
๋ 14๋ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ๋ฅผ ๋ํ๋ด๋ ์ฌ์๋,14 is a perspective view showing a plasma extraction kit according to a second embodiment of the present invention,
๋ 15๋ ๋ 14์ ์ ๊ฐ์ฌ์๋, FIG. 15 is a cutaway perspective view of FIG. 14; FIG.
๋ 16์ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ์ ๋จ๋ฉด๋,. 16 is a cross-sectional view of the plasma extraction kit according to a second embodiment of the present invention.
๋ 17 ๋ฐ ๋ 18์ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ์ ์ธํต์ ๋ํ๋ด๋ ๋๋ฉด,17 and 18 are views showing the outer cylinder of the plasma extraction kit according to a second embodiment of the present invention,
๋ 19๋ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ์ ๊ฐํ ์บก์ ๋ํ๋ด๋ ๋๋ฉด, 19 is a view showing the opening and closing cap of the plasma extraction kit according to a second embodiment of the present invention,
๋ 20์ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ์ ๋ฎ๊ฐ๋ถ๋ฅผ ๋ํ๋ด๋ ๋๋ฉด, 20 is a view showing a cover portion of the plasma extraction kit according to a second embodiment of the present invention,
๋ 21์ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ์ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ๋ฅผ ๋ํ๋ด๋ ๋๋ฉด, 21 is a view showing the connection blade portion of the plasma extraction kit according to a second embodiment of the present invention,
๋ 22๋ ๋ณธ ๋ฐ๋ช ์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ์ ์ฌ์ฉ์๋ฅผ ๋ํ๋ด๋ ๋๋ฉด์ด๋ค. 22 is a diagram showing an example of use of the plasma extraction kit according to the second embodiment of the present invention.
๋ณธ ๋ฐ๋ช ์ ์ํ ํ์ฅ์ถ์ถํคํธ๋, ์๋จ์ด ๊ฐ๊ตฌ๋๊ณ ํ๋จ์ด ํ์๋์ด ์๋ ์ํตํ ํ์์ ๋ณธ์ฒด๋ถ์, ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ ์ค์๋ถ๋ถ์ ์ฒด๊ฒฐ๋๋ฉฐ, ์ค์๋ถ์ ์ง๊ฒฝ์ด ์๊ณ ์๋จ๋ถ๋ ์ค์๋ถ๋ฅผ ํฅํ์ฌ ์ง๊ฒฝ์ด ์ ์ฐจ ๊ฐ์ํ๋ ํ ์ดํผ ํ์์ผ๋ก ํ์ฑ๋ ๊น๋๊ธฐ๋ถ์, ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๋จ์ ํ์ํ๋ ๋ฎ๊ฐ๋ถ๋ฅผ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. Plasma extraction kit according to the present invention, the upper end is opened and the lower end is closed, the main body portion is fastened to the inner central portion of the main body portion, the diameter of the center portion is small and both ends are gradually reduced in diameter toward the center portion A funnel formed in a tapered shape, and a cover portion for closing the upper end of the main body portion.
์ฌ๊ธฐ์, ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด์ธก๋ฉด์๋ ์๊ธฐ ๊น๋๊ธฐ๋ถ๋ฅผ ์ผ์ ์์น์ ์ ์งํ๋๋ก ์ดํ์ ๋ฐฉ์งํ๋ ๊ฑธ๋ฆผํฑ์ด ํ์ฑ๋์ด ์๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค.Here, the inner side of the main body portion is characterized in that the locking step is formed to prevent the separation to maintain the funnel in a predetermined position.
์๊ธฐ ๋ฎ๊ฐ๋ถ์ ๊ฐํ๊ฐ๋ฅํ๊ฒ ์ฒด๊ฒฐ๋๋ฉฐ, ํ์๋ก๋ถํฐ ์ถ์ถํ ํ์ก์ ์ฃผ์ ํ๋ ์ฃผ์ฌ๊ธฐ์ ์ฃผ์ฌ๋ฐ๋์ด ์ฝ์ ๋ ์ ์๋ ์ฃผ์ ํ์ ์ผ์ธก๋ฉด์ ๊ตฌ๋นํ ๊ฐํ ์บก์ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. The opening and closing is fastened to the cover portion, characterized in that it comprises an opening and closing cap having an injection hole on one side that can be inserted into the needle of the syringe for injecting blood extracted from the patient.
์ฌ๊ธฐ์, ์๊ธฐ ๊ฐํ ์บก์, ์๋ถ๋ฉด ์ค์์ ํ์ฑ๋ ๊ฐ๊ตฌ๋ฅผ ํ์ํ๋ฉฐ, ์์ฌ๋ถ๋ฆฌ๋ ํ์ก์ ๋คํ์ํ ํ์ฅ์ ์ถ์ถํ๊ธฐ ์ํ ์ฃผ์ฌ๊ธฐ๊ฐ ์ฉ์ดํ๊ฒ ์ฝ์ ๋ ์ ์๋ ์ฌ์ง๋ก ํ์ฑ๋ ๋ฐํ๋ง์ ๋์ฑ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. Here, the opening and closing cap, and closes the opening formed in the center of the upper surface, characterized in that it further comprises a sealing membrane formed of a material that can be easily inserted into the syringe for extracting the multi-platelet plasma of the centrifuged blood.
์๊ธฐ ๋ฎ๊ฐ๋ถ๋ ์ค์์ ์ฒด๊ฒฐํ์ด ํ์ฑ๋๊ณ , ์๊ธฐ ์ฒด๊ฒฐํ๋ก๋ถํฐ ๋์ถ๋๋ ๋์ถ๋ถ๋ฅผ ๊ตฌ๋นํ๋ฉฐ, ์๊ธฐ ๊ฐํ ์บก์, ํ๋ถ๋๋จ์ผ๋ก๋ถํฐ ์ธ์ธก์ผ๋ก ๋์ถ๋์ด ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ๋์ถ๋ถ์ ๊ฑธ๋ฆผ๊ณ ์ ๋๋ ๊ฑธ๋ฆผ๋๊ธฐ๋ฅผ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. The cover part has a fastening hole formed at the center thereof, and includes a protrusion projecting from the fastening hole, and the opening / closing cap is provided with a locking protrusion projecting outward from the lower end to be locked to the protrusion of the cover part. .
์๊ธฐ ๊น๋๊ธฐ๋ถ์ ํ๋ถ์ ๋ง๋ จ๋๋ฉฐ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ ํ๋จ์ ์ค์น๋์ด ์ฃผ์ ๋๋ ํ์ก์ ์์ฉํ๋ ํ์ก์ ์ฅ๋ถ๋ฅผ ๋์ฑ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. It is provided on the lower portion of the funnel, characterized in that it further comprises a blood storage unit for receiving the blood is installed is installed in the inner bottom of the main body portion.
์๊ธฐ ๊น๋๊ธฐ๋ถ๋, ์ค์๋ถ๋ถ์ ์ง๊ฒฝ์ด ์๊ณ ์๋จ๋ถ๋ถ์ ์ค์๋ถ๋ถ์ ํฅํ์ฌ ์ง๊ฒฝ์ด ์ ์ฐจ ๊ฐ์ํ๋ ํ ์ดํผ ํ์์ผ๋ก ํ์ฑ๋ ๋ดํต๊ณผ, ์ํ๋ถ๊ฐ ๊ฐ๊ตฌ๋๊ณ ์๊ธฐ ๋ดํต์ ์๋จ๋ถ๊ฐ ์ฒด๊ฒฐ๋๋ ์ค๊ณต์ ์ํตํ์์ผ๋ก ํ์ฑ๋ ์ธํต์ผ๋ก ํ์ฑ๋๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. The funnel is formed of an inner cylinder formed in a tapered shape in which the diameter of the center portion is small and both ends thereof are tapered in diameter gradually decreasing toward the center portion, and an outer cylinder formed in a hollow cylindrical shape in which upper and lower portions are opened and both ends of the inner cylinder are fastened. It is characterized by.
์ฌ๊ธฐ์, ์๊ธฐ ์ธํต์ ์ธ์ธก์ผ๋ก ๋์ถ๋ ์ฒด๊ฒฐ๋๊ธฐ๊ฐ ํ์ฑ๋์ด ์๊ณ , ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด์ธก๋ฉด์๋ ๋ด์ธก์ผ๋ก ์ค๋ชฉํ๊ฒ ์ ๊ฐ๋๋ฉฐ ์ผ์ ํญ์ ๊ตฌ๋นํ์ฌ ์๊ธฐ ์ฒด๊ฒฐ๋๊ธฐ๊ฐ ์ฝ์ ๋๋ฉฐ ์๊ธฐ ์ฒด๊ฒฐ๋๊ธฐ์ ์ด๋์ ์ ํํ๋ ์ฒด๊ฒฐํ์ด ํ์ฑ๋์ด ์๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. Here, the outer cylinder is formed with a fastening protrusion protruding outward, the inner surface of the main body portion is indented concave inwardly and has a predetermined width, the fastening protrusion is inserted into the fastening groove for limiting the movement of the fastening protrusion is It is characterized by being formed.
์ฌ๊ธฐ์, ์ผ๋๋จ์ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์ฐ๊ฒฐ๋๊ณ ํ๋๋จ์ ์ ๊ณก๋์ด ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ๋์ฌ์ฐ์ ๋ง๋ฌผ๋ฆฌ๋ ์ฒด๊ฒฐ๋๊ธฐ๊ฐ ํ์ฑ๋ ๊ธฐ๋ค๋ ๋ง๋ํ์์ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ๋ฅผ ๋์ฑ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. Here, one end is connected to the funnel and the other end is bent and characterized in that it further comprises an elongated rod-shaped connecting blade formed with a fastening projection engaging the thread of the cover portion.
์ฌ๊ธฐ์, ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ๋, ์ผ๋๋จ์ T์ ํ์์ผ๋ก ํ์ฑ๋ ์ 1 ๋ ๊ฐ๋ถ์, ํ๋๋จ์ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ํ์ฑ๋ ์ฒด๊ฒฐ๋์ฌ์ ์ฒด๊ฒฐ๋๋ ์ฐ๊ฒฐ๋๊ธฐ๋ฅผ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. Here, the connection blade portion is characterized in that it comprises a first wing portion formed in a T-shape at one end, and a connecting projection fastened to the fastening screw formed on the cover portion at the other end.
์ฌ๊ธฐ์, ์๊ธฐ ์ธํต์ ์๋จ๋ถ๋ถ์๋ T์ ํ์์ผ๋ก ์ ๊ฐ๋์ด ํ์ฑ๋๋ฉฐ ์๊ธฐ ์ 1 ๋ ๊ฐ๋ถ๊ฐ ์ฒด๊ฒฐ๋๋ ๊ฑธ๋ฆผ๊ณ ์ ํ์ ๋์ฑ ๊ตฌ๋นํ๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค.Here, the upper end portion of the outer cylinder is formed by cutting in a T-shape and characterized in that it further comprises a locking groove that is fastened to the first wing portion.
๋ํ, ํ์ก์ผ๋ก๋ถํฐ ํ์ฅ ์ฑ๋ถ์ ์ถ์ถํ๋ ํ์ฅ ์ถ์ถ ํคํธ์ ์ํด, ์ฃผ์ ๋ ํ์ก์ 1์ฐจ๋ก ์์ฌ๋ถ๋ฆฌํ ํ ์์ฌ๋ถ๋ฆฌ๋ ํ์ก์ PRP์ PPP์ ์ ํ๊ตฌ๋ก๋ถํฐ 2์ฐจ ์์ฌ๋ถ๋ฆฌ์ ์ํด ํ์ฅ์ ๋์ฑ ์ถ์ถํ๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ๋์ฑ ํฌํจํ์ฌ ๊ตฌ์ฑ๋๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. In addition, by the plasma extraction kit for extracting the plasma components from the blood, the second centrifugal centrifugation to further extract the plasma from the PRP, PPP and erythrocytes of the centrifuged blood by centrifugation of the injected blood first Characterized in that further comprises a separation tube.
์๊ธฐ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ์ํตํ ํ์์ผ๋ก ํ์ฑ๋์ด ์๊ณ , ์๊ธฐ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ํ๋จ๋ถ์๋ ์๋ถ๋ณด๋ค ์ง๊ฒฝ์ด ์์ ์ 2 ๋ชจ์ธ๊ด๊ณผ, ์๊ธฐ ์ 2 ๋ชจ์ธ๊ด์ ๋๋จ๋ถ๋ถ์๋ ์ง๊ฒฝ์ด ์ ์ฐจ ์์์ง๋ ์ฒจ๋จ๋ถ๊ฐ ํ์ฑ๋์ด ์๋ ๊ฒ์ ํน์ง์ผ๋ก ํ๋ค. The secondary centrifuge tube is formed in a cylindrical shape, the lower end of the secondary centrifuge tube is formed with a second capillary tube having a smaller diameter than the upper portion, the tip portion of the second capillary tube is gradually reduced in diameter is formed It is characterized by being.
์ดํ, ์ฒจ๋ถ๋ ๋๋ฉด์ ์ฐธ์กฐํ์ฌ ๋ณธ ๋ฐ๋ช ์ ์ํ ํ์ฅ ์ถ์ถ ํคํธ์ ๋ํ์ฌ ์ค์์๋ก์จ ์์ธํ๊ฒ ์ค๋ช ํ๋ค. Hereinafter, with reference to the accompanying drawings will be described in detail with respect to the plasma extraction kit according to the present invention.
<์ค์์ 1><Example 1>
๋ 2 ๋ด์ง ๋ 13์ ๋ณธ ๋ฐ๋ช ์ ์ 1 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ๋ฅผ ๋ํ๋ด๋ ๋๋ฉด์ด๋ค. 2 to 13 is a view showing a plasma extraction kit according to a first embodiment of the present invention.
๋ 2 ๋ด์ง ๋ 13์ ๋ํ๋ ๋ฐ์ ๊ฐ์ด, ๋ณธ ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ(1)๋ ๋ชจ์์ด ๋ค๋ฅธ ๋ ๊ฐ์ ์์ฌ๊ด ์ค๋ฆฐ๋๋ก ์ ๊ณต์ด ๋๋ฉฐ, ๊ฐ๊ฐ ๋ณธ์ฒด๋ถ, 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ผ๋ก ์ฌ์ฉ๋๋ฉฐ, ๊ฐ๊ฐ์ ๋ชจ์์ด ์ถ์ถ๊ณผ์ ์์ ์ฉ์ดํ๊ฒ ์ฌ์ฉ๋๋๋ก ๊ณ ์๋ ์ํ๋ก ์ ๊ณต๋๋ค.As shown in Figures 2 to 13, the plasma extraction kit 1 according to the present embodiment is provided as two centrifuge tube cylinders of different shapes, respectively, used as a main body portion, secondary centrifuge tube, each The shape is provided as designed to be easily used in the extraction process.
์๊ธฐ ๋ณธ์ฒด๋ถ์ ํ์ ํ๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ์
๊ตฌ๋ ๋ฎ๊ฐ(40, 40')์ ์ํด ๋ฐํ๋๊ณ , ๋ฎ๊ฐ์ ์ค์๋ถ์๋ ์ฃผ์ฌ๋ฐ๋์ด ๋ค์ด๊ฐ ์ ์๋ ์ฒ๊ณต ๊ตฌ๋ฉ(42, 42')์ด ํ์ฑ๋์ด์๊ณ , ์๋ถ ๋ฎ๊ฐ๋ฅผ ๋ถ๋ฆฌํ์ง ์๊ณ ์๊ธฐ ์ฒ๊ณต๊ตฌ๋ฉ์ ํตํด ์ฃผ์ฌ๋ฐ๋์ ์ฝ์
ํ์ฌ ํ์ก์ ์ฃผ์
ํ ์ ์๋๋ก ๊ตฌ์ฑ๋์ด ์์ผ๋ฉฐ, ์ธ๋ถ ๊ฐ์ผ์ผ๋ก๋ถํฐ ์์ ํ๋๋ก ์๊ธฐ ๋ฎ๊ฐ๋ ์ฐ์ง์ ํ์ฑ ์ฌ์ง๋ก ํ์ฑ๋์ด ์๋ค.The inlet of the main body and the secondary centrifuge tube, which will be described later, is closed by
์์ ํ ๋ฎ๊ฐ๋ ๋ณธ์ฒด๋ถ ๋ด๋ถ๋ก ์ฝ์
๋๋ ๋ถ๋ถ์ด ์๋๋ฐ ๊ทธ ํ๋ฉด์ ๋์ฌ์ฐ(41, 41')์ด ํ์ฑ๋์ด ์๋ค.The above-described cover has a portion to be inserted into the main body portion, the surface of which is formed with
๋ณธ์ฒด๋ถ์ ๋ด๋ถ์๋ ์ํต ํ์์ผ๋ก ํ์ฑ๋ ๊น๋๊ธฐ๋ถ(20)๊ฐ ์ฝ์
๋์ด ์์ผ๋ฉฐ ๊น๋๊ธฐ๋ถ(20)์ ์ค์์๋ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์๋ถ์ ํ๋ถ๋ฅผ ๊ดํตํ๋ ๊ธธ๊ณ ์ข์ ์ง๊ฒฝ์ ๋ชจ์ธ๊ด(23)์ด ํ์ฑ๋์ด ์๋ค. ์ด ๋ชจ์ธ๊ด์ ์์ชฝ๊ณผ ์๋์ชฝ ๋๋ถ๋ถ์์๋ ์ง๊ฒฝ์ด ์ ์ ์ข์์ง๊ฑฐ๋ ์ ์ฐจ ๋์ด์ง๋ ๊น๋๊ธฐ ๋ชจ์์ ํ
์ดํผ๋ถ(21,22)๊ฐ ํ์ฑ๋์ด ์๊ณ , ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๊ธฐ ๊น๋๊ธฐ๋ถ๋ ํฌ๋ช
ํ ์ฌ์ง๋ก ํ์ฑ๋์ด ์ธ๋ถ์์ ๋ด๋ถ ๋ชจ์ธ๊ด์ ์๋ ํ์ก ์ฑ๋ถ์ ์ ๋ช
ํ๊ฒ ๋ณผ ์ ์๋ค. ์ฝ์
๋ ์๊ธฐ ๊น๋๊ธฐ๋ถ๋ ๋ณธ์ฒด๋ถ์ ๋ด๊ฒฝ๊ณผ ์ ํํ๊ฒ ์ธ์ ํ์ฌ ๋ฐ์ฐฉ๋ ์ํ๋ก ์ ๊ณต๋๋ค. ๊น๋๊ธฐ ๋ชจ์์ ํ
์ดํผ๋ถ์ ๊ฒฝ์ฌ๋ ์๋ถ์ ํ๋ถ๊ฐ ๊ฐ๊ฐ ๋ค๋ฅด๊ฒ ์ค๊ณ๋์ด ์๋ค.A
์์ ํ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์๋จ๋ถ์๋ ๋ ๊ฐ์ ํญ์ด ์ข๊ณ ๊ธด ๋ง๋๊ธฐ ํํ์ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ(24)๊ฐ ์๋ก ๋ป์ด์๋๋ฐ ์๊ธฐ ๋ฎ๊ฐ๊น์ง ์ด๋ฅด๊ณ ์์ผ๋ฉฐ ๊ทธ ๋์ ๋ด์ธก์ผ๋ก ์ ๊ณก๋์ด ์ฒด๊ฒฐ๋๊ธฐ(25)๊ฐ ํ์ฑ๋์ด ๋ฎ๊ฐ ํ๋จ๋ถ์ ๋์ฌ์ฐ(26)์ ๋ฌผ๋ฆด ์ ์๋ ์ํ๋ก ์ ๊ณต๋๋ค.In the upper end of the funnel portion, two narrow, long rod-shaped connecting
์๊ธฐ ๋ฎ๊ฐ(40)๋ฅผ ๋๋ฆฌ๊ฒ ๋๋ฉด ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ์ฐ๊ฒฐ๋ ํ๋ถ์ ์๊ธฐ ๊น๋๊ธฐ๋ถ๊ฐ ๋ฎ๊ฐ์ ๋์ฌ์ฐ์ ๋ฐ๋ผ ์ํ ์ด๋์ ํ๋ฉด์ ๋์ด๊ฐ ๋ณํ๊ฒ ๋๋ค. ๋ฎ๊ฐ์ ์ธก๋ฉด์ ํ์ ์ ๋ง์ฐฐ๋ ฅ์ ๋์ด๊ธฐ ์ํด ์์ฒ (43)๋ก ๋์ด์๋คWhen the
์๊ธฐ ๊น๋๊ธฐ๋ถ๋ ๋ฎ๊ฐ์ ๋ ๊ฐ๋ก ์ฐ๊ฒฐ๋์ด ์์ ๋ ๋ณธ์ฒด๋ถ์ ๋ฐ๋ฅ๋ฉด๊น์ง ๋ด๋ ค์ ์์ง ์๊ณ ์ค๊ฐ์ ๋ ์๋ ์ํ์ด๋ค. ์๊ธฐ ๊น๋๊ธฐ๋ถ๊ฐ ์์นํ๋ ๋ถ๋ถ์ ์ค๋ฆฐ๋ ์๋จ, ํ๋จ์๋ ์ผ์ ๊ฑฐ๋ฆฌ๋งํผ ๊ฐ๊ฒฉ์ ๋๊ณ ๊ฑธ๋ฆผํฑ(27)์ด ๋ง๋ค์ด์ ธ ์์ด ์ํต๊ตฌ์กฐ๋ฌผ์ด ๋ฐ๋ฅ์ ๋ฟ๊ฑฐ๋ ์๋ก ๋น ์ ธ๋์ค์ง ๋ชปํ๋๋ก ํ๊ณ๋ฅผ ๋๊ณ ์๋ ์ํ๋ก ์ ๊ณต๋๋ค.When the funnel is connected to the cover by a wing, it is floating in the middle without descending to the bottom of the main body. The top and bottom of the cylinder of the portion where the funnel is located is provided with a locking
์๊ธฐ ๊น๋๊ธฐ๋ถ์ ํ๋ถ ๊ณต๊ฐ์ ์์ฌ๋ถ๋ฆฌ์ ์ ํ๊ตฌ๊ฐ ๋ชจ์ด๋ ๊ณต๊ฐ์ด๋ฉฐ ๊ฐ ์ฌ๋์ ์ ํ๊ตฌ ์์ ๋ค์์ฑ์ ๊ณ์ฐํ์ฌ ์ ์ ํ ์ฉ๋์ ๊ณต๊ฐ์ ํ๋ณดํ๋ ํ์ก์ ์ฅ๋ถ(30)์ด๋ค.The lower space of the funnel portion is a space in which red blood cells are collected during centrifugation, and the
2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด(2)์ ๋๋ต ์ํตํ ํ์์ผ๋ก ํ์ฑ๋์ด ์๊ณ , ๊ทธ ํ๋จ๋ถ์๋ ์๋ถ๋ณด๋ค ์ง๊ฒฝ์ด ์์ ์ข์ ์ 2 ๋ชจ์ธ๊ด(71)์ด ํ์ฑ๋์ด ์์ผ๋ฉฐ, ์๊ธฐ ์ 2 ๋ชจ์ธ๊ด(71)์ ๋๋จ๋ถ๋ถ์๋ ์๋ฟํ์ผ๋ก ๋์ด ์ง๊ฒฝ์ด ๋ ์์์ง๋ค๊ฐ ๋์ ๊ผญ์ง์ ์ผ๋ก ๋๋๋ ์ฒจ๋จ๋ถ(72)๊ฐ ํ์ฑ๋์ด ์๋ค.The secondary centrifuge tube (2) is formed in a substantially cylindrical shape, the lower end of which is formed a narrow second capillary tube (71) having a smaller diameter than the upper portion, and the end of the second capillary tube (71) is conical. As the diameter becomes smaller, the
PRP๋ฅผ ์ถ์ถํ๊ธฐ ์ํ ์์ฌ๋ถ๋ฆฌ๋ ํต์์ ์ผ๋ก 2์ฐจ๋ก๋ฅผ ์ค์ํ๋ค. 1์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ์์ธต์ ํ์ฅ๊ณผ ํ์ธต์ ์ ํ๊ตฌ ๋น์จ์ ์ธก์ ํ๊ณ ๊ทธ ์์น๋ฅผ ์กฐ์ ํ ๋ค 2์ฐจ ์์ฌ๋ถ๋ฆฌ๋ฅผ ์ค์ํ๋๋ฐ ์ง๊ธ๊น์ง ๊ฐ๋ฐ๋ ์ ํ๋ค์ ์ผ์ฒดํ ์์ฌ๊ด์์ 2์ฐจ๋ก ๋ชจ๋ ์คํํ๊ณ ์๋ค. ๋ณธ ์ค์์์ ์ํ ํ์ฅ ์ถ์ถ ํคํธ๋ 1์ฐจ ์์ฌ๋ถ๋ฆฌ์ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๋ฅผ ๊ฐ๊ธฐ ๋ค๋ฅธ ์์ฌ๋ถ๋ฆฌ๊ด์์ ์ํํ๋ ๊ฒ์ด ํน์ง์ด๋ค.Centrifugation to extract the PRP is usually carried out twice. After the first centrifugation, the ratio of the upper plasma and the lower red blood cells is measured, and the position is adjusted. Then, the second centrifugation is performed. The products developed so far are performed twice in an integrated centrifuge tube. The plasma extraction kit according to the present embodiment is characterized in that the first centrifugation and the second centrifugation are performed in different centrifuge tubes.
์์ ํ ๋ฐ์ ๊ฐ์ด, ์ฌ๋์ ์ ํ๊ตฌ์ ์์ ๊ฐ๊ฐ ๋ค๋ฅด๋ฏ๋ก ์ด ํธ์ฐจ์ ๋ฒ์๋ฅผ ์์ฉํด์ ์์ํ ์ถ์ถ์ ํ๋๋ก ๊ณ ์๋ ๊ฒ์ด ๋ณธ ์ค์์์ ํ์ฅ์ถ์ถํคํธ(1)์ด๋ค.As described above, since the amount of human red blood cells is different, the plasma extraction kit 1 of the present embodiment is designed to accommodate the range of this deviation and facilitate extraction.
ํ์ฅ์ถ์ถํคํธ(1)๋ ์์์๋ถํฐ ์๋ถ๊ณต๊ฐ(10), ๊น๋๊ธฐ๋ถ(20), ํ์ก์ ์ฅ๋ถ(30)๋ก ๋๋์ด์ง๋ค. ์์ฌ๋ถ๋ฆฌ ํ ์๋ถ๊ณต๊ฐ(10)์ ํ์ฅ์ด ๋ชจ์ด๋ ๊ตฌ๊ฐ์ด๊ณ , ํ์ก์ ์ฅ๋ถ(30)๋ ์ ํ๊ตฌ๊ฐ ๋ชจ์ด๋ ๊ณต๊ฐ์ด๋ฉฐ, ๊น๋๊ธฐ๋ถ(20)๋ ๋ ์ธต์ ๊ฒฝ๊ณ๋ถ์๋ฅผ ์ด๋ฃจ๋๋ก ์ค๊ณ๋์ด์๋ค. ๊น๋๊ธฐ๋ถ์ ์๋จ(21)๊ณผ ํ๋จ์ด ์ง๊ฒฝ์ด ์ ์ฐจ ์์์ง๊ฑฐ๋ ์ ์ฐจ ์ปค์ง๋ ๊น๋๊ธฐ ๋ชจ์์ ํ
์ดํผ๋ถ(21, 22)๊ฐ ํ์ฑ๋์ด ์์ฌ ๋ถ๋ฆฌ์ ํ๊ตฌ ์ฑ๋ถ๋ค์ด ์ ์ด๋๋ ์ ์๋๋ก ๊ตฌ์ฑ๋์ด ์๋ค.The plasma extraction kit 1 is divided into an
๋ํ, ์๊ธฐ ํ์ฅ์ถ์ถํคํธ๋ ํ๊ท ์ ํ๊ตฌ๋์ ๊ธฐ์ค์ผ๋ก ์ ์ฒด์ ์์ ๋ฐ ํ์ 80-90%์ ๋ถํฌ๋๋ฅผ ๋ณด์ด๋ ๋ฒ์์ ์ ํ๊ตฌ๊ฐ ํ๋ถ๊ณต๊ฐ ๋ฐ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์ข๊ณ ๊ธธ๋ค๋ ๋ชจ์ธ๊ด(23)์ ์์ฉ๋ ์ ์๋๋ก ์ฉ๋์ด ์ค๊ณ๋์ด ์๋ค. ๋ฐ๋ผ์ 1์ฐจ ์์ฌ๋ถ๋ฆฌ๋ฅผ ํ๊ณ ๋๋ฉด ์ ํ๊ตฌ ์ต์์ธต์ ์์น๊ฐ ๋ชจ์ธ๊ด๋ด์ ์ด๋ ํ ๋ถ๋ถ์ ์์นํ๊ฒ ๋๋ค. ๊ทธ ๋ฐ๋ก ์์ชฝ์ผ๋ก PRP๊ฐ ์์ฌ๋ถ๋ฆฌ๊ด์ ๋จ๋ฉด์ ์ด ์ ์ด์ง ๋งํผ ๋ฐ์ง๋์ด ๋๊ป๊ฒ ์์ฌ ์๊ฒ ๋๋ค. ์ด ๊ฒฝ์ฐ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ๋์ด ์กฐ์ ์ด ํ์์์ด ๋ฐ๋ก ๋๋ค์ ์ฝ์
ํ์ฌ PRP๋ฅผ ํฌํจํ ๊ทธ ์์ชฝ์ PPP๋ฅผ ๋ชจ๋ ํ๊บผ๋ฒ์ ์ถ์ถํ๋ค. In addition, the plasma extraction kit has a capacity designed so that the red blood cells in the range showing the distribution of the upper and lower 80-90% of the total based on the average red blood cells can be accommodated in the lower space and the narrow and
์ด ๋ ์ ํ๊ตฌ ์์ธต๋ฉด๊ณผ PRP ํ์ธต๋ฉด์ ๊ฒฝ๊ณ๋ถ์์์๋ ์ ํ๊ตฌ์ ํ์ํ ๋ ์ข ๋ฅ์ ํ๊ตฌ๊ฐ ์๋ก ์ฝํ์๋๋ฐ ์ด ๋ถ๋ถ์ ์ถ์ถํ๋ ๋จ๊ณ์์ ๊ฐ๋ฅํ ํ ์ ํ๊ตฌ๋ฅผ ํฌํจํ์ง ์๊ณ ์ถ์ถํ๊ธฐ ์ํด ์์ ์๊ฐ์ด ๋ง์ด ๊ฑธ๋ฆฌ๊ฒ ๋๋ฉฐ, ์กฐ์์์ ์๋ จ๋์ ๋ฐ๋ผ์ ์ถ์ถ์ก์ ํ์ง์ ํธ์ฐจ๊ฐ ์๊ธฐ๊ฒ ๋๋ค. ์ ํ๊ตฌ๋ฅผ ํก์ ํ์ง ์๊ธฐ ์ํด์๋ ๊ฒฝ๊ณ๋ฉด์์ ์ ํ๊ตฌ์ ์์ผ์๋ ์๋น๋์ ํ์ํ ์ถ์ถ์ ํฌ๊ธฐํด์ผ ํ๊ณ , ํ์ํ์ ์ถ์ถ์จ์ ๋์ด๊ณ ์ถ์ผ๋ฉด ์ด์ฉ์ ์์ด ์ ํ๊ตฌ๋ฅผ ๊ฐ์ด ํก์ ํ ์ ๋ฐ์ ์๋ค๋ ๋ฌธ์ ๊ฐ ์๋ค. ๊ทธ๋ฌ๋ ๋ณธ ์ฅ์น์์๋ 2์ฐจ๋ก์ ๊ณต์ ์ ํตํด ํก์ ๋ ์ ํ๊ตฌ๋ฅผ ๋ฐฐ์ ํ ์ ์์ผ๋ฏ๋ก ์์ธต์ ์ ํ๊ตฌ์ธต์ ํฌํจํ์ฌ ๊ฒฝ๊ณ๋ถ์์ PRP์ ํจ๊ป ๋ชจ๋ PRP ๋ฐ PPP๋ฅผ ์ ์ํ๊ฒ ํก์ ํ๋ฉด ๋๊ณ ์ด๋ก์ 1์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์์์ ๊ณต์ ์ ๋์ด ๋๋ค.At this time, at the boundary between the upper surface of the red blood cells and the lower surface of the PRP, two types of blood cells are entangled with each other. In the step of extracting this part, it takes a long time to extract the red blood cells as much as possible. Depending on the skill, the quality of the extract will vary. In order not to inhale erythrocytes, a significant amount of platelet extraction, which is entangled with erythrocytes at the interface, must be given up, and if you want to increase the extraction rate of platelets, you have no choice but to inhale erythrocytes together. However, in this device, the inhaled red blood cells can be excluded through the second process, so all the PRP and PPP can be sucked quickly together with the PRP at the boundary including the upper red blood cell layer. Ends.
๋ 7 ๋ฐ ๋ 8์ ๋ํ๋ธ ๋ฐ์ ๊ฐ์ด, 1์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ์ฌ๋์ ๋ฐ๋ผ ๊ณผ๋ํ๊ฒ ๋ง์ ์ ํ๊ตฌ๋ ๊ณผ์ํ ์ ํ๊ตฌ๋ก ์ธํด ๊ธฐ๋ค๋ ๋ชจ์ธ๊ด์ด ์์ฉํ์ง ๋ชปํ๋ ๋ฒ์์ ์๊ฒ ๋๋ฉด ์๊ธฐ ๋ฎ๊ฐ(41)๋ฅผ ๋๋ ค ์๊ธฐ ๋ด๋ถ๊ด์ ๋์ด๋ฅผ ์กฐ์ ํ์ฌ PRP์ธต์ ๋ชจ์ธ๊ด๋ด์ ์ด๋ ํ ๋ถ๋ถ์ ์์นํ๊ฒ ํ๊ณ ์์ ํ ๋ฐฉ๋ฒ๋๋ก PRP ๋ฐ PPP๋ฅผ ์ถ์ถํ๋ค. As shown in Fig. 7 and 8, after the first centrifugation, if the elongated capillaries are not accommodated due to excessive red blood cells or excessive red blood cells, the
์ด๋์๋ ๋ชจ์ธ๊ด์ ๊ธธ์ด๊ฐ ๋งค์ฐ ๊ธธ์ด ์์น์กฐ์ ์ ์กฐ๊ธ๋ง ํ์ฌ๋ PRP์ ์์น๊ฐ ๋ชจ์ธ๊ด์ ์์ฉ ๋ฒ์ ๋ด์ ๋ค์ด์ค๋ฏ๋ก ๋ชจ์ธ๊ด์ ๊ธธ์ด๊ฐ ์ข์ ์ ํ๊ณผ ๋ค๋ฅด๊ฒ ํจ์ฌ ์ฉ์ดํ ์ถ์ถ์ด ๊ฐ๋ฅํ๋ค.At this time, the length of the capillary tube is very long, so even if the position adjustment is a little, the position of the PRP falls within the acceptance range of the capillary tube, which is much easier to extract than the narrow capillary product.
์ด๋ ๊ฒ ์ถ์ถํ PPP, PRP ๋ฐ ์๋์ ํก์ ๋ ์ ํ๊ตฌ๋ฅผ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด(2)์ผ๋ก ์ฎ๊ฒจ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๋ฅผ ํ๋ค.The extracted PPP, PRP and a small amount of sucked red blood cells are transferred to the secondary centrifuge tube (2) and subjected to secondary centrifugation.
๋ 9์ ๋ํ๋ธ ๋ฐ์ ๊ฐ์ด, 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด(2)์ ๋๋ต ์ํตํ ํ์์ผ๋ก ํ์ฑ๋์ด ์๊ณ , ๊ทธ ํ๋จ๋ถ์๋ ์๋ถ๋ณด๋ค ์ง๊ฒฝ์ด ์์ ์ข์ ์ 2 ๋ชจ์ธ๊ด(71)์ด ํ์ฑ๋์ด ์์ผ๋ฉฐ, ์๊ธฐ ์ 2 ๋ชจ์ธ๊ด(71)์ ๋๋จ๋ถ๋ถ์๋ ์๋ฟํ์ผ๋ก ๋์ด ์ง๊ฒฝ์ด ๋ ์์์ง๋ค๊ฐ ๋์ ๊ผญ์ง์ ์ผ๋ก ๋๋๋ ์ฒจ๋จ๋ถ(72)๊ฐ ํ์ฑ๋์ด ์๋ค.As shown in FIG. 9, the
์ด ํน์ํ๊ฒ ๊ณ ์๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ผ๋ก ์์ฌ๋ถ๋ฆฌ๋ฅผ ํ๊ฒ ๋๋ฉด ์๋ถ๋ถํฐ PPP, PRP ๊ทธ๋ฆฌ๊ณ ๊ฐ์ด ํก์ ๋ ์๋์ ์ ํ๊ตฌ์ธต์ด ํ์ฑ๋๋ค.Centrifugation with this specially designed secondary centrifuge tube forms PPP, PRP, and a small amount of red blood cells inhaled from the top.
์๋ถ์ PPP(81)๋ ํ์ํ์ง ์์ผ๋ฏ๋ก ์๋๋ง ๋จ๊ธฐ๊ณ ์ถ์ถํ ๋ค ํ๊ธฐํ๋ค.Since the
์ด์ ๋จ์ ๊ฒ์ ์์ชฝ๋ถํฐ ์๋์ PPP(82), PRP(83), ์๋์ ์ ํ๊ตฌ(84)์ด๋ค.All that remains is a small amount of
๊ฐ์ฅ ํ๋ถ์ ์ ํ๊ตฌ๋ ์๋์ด๋ฏ๋ก 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ์๊ธฐ ์ฒจ๋จ๋ถ(72) ์์ ๋ชจ๋ ์์ฉ๋์ด์ง๋ค.The lowest red blood cells are all contained within the
์ด์ ๋๋ค์ PRP ์ธต์ ๋ฟ๊ฒ ํ์ฌ ํ๋ถ์ ์ ํ๊ตฌ๋ฅผ ์ ์ธํ ๋๋จธ์ง ์ก์ ์ถ์ถํ๊ฒ ๋๋๋ฐ ํ๋ถ์ ์ ํ๊ตฌ๋ ๋งค์ฐ ์ข์ ๊ณต๊ฐ์๋ง ๋ชจ์ฌ ์์ผ๋ฏ๋ก ์ด๋ค์ ๊ฑฐ์ ๊ฑด๋๋ฆฌ์ง ์๊ณ ์๋์ PPP ๋ฐ PRP๋ง์ ๊ทน๋๋ก ์ ๋ณํ์ฌ ์ถ์ถํ ์ ์๊ฒ ๋์ด ๊ณ ์๋, ๊ณ ๋์ถ์จ์ PRP๋ฅผ ์ป์ ์ ์๊ฒ ๋๋ค.Now, the needle touches the PRP layer and extracts the remaining liquid except the lower red blood cells, and since the lower red blood cells are collected only in a very narrow space, it is possible to extract only a small amount of PPP and PRP with very little touch without extracting them. High concentration PRP can be obtained.
๋ ๋ค๋ฅธ ๋ฐฉ๋ฒ์ผ๋ก๋ ์ ์ผ ๋จผ์ ๋งจ ์๋์ธต์ ์ฒจ๋จ๋ถ ๊ณต๊ฐ์ ์ ํ๊ตฌ์ธต๊น์ง ๋๋ค์ ๋ฃ์ด ์ ํ๊ตฌ๋ฅผ ์ถ์ถํ๊ณ ํ๊ธฐํ ๋ค, ๋ ๋ฒ์งธ๋ก ์์ธต์ PPP๋ฅผ ์ถ์ถํ๊ณ ํ๊ธฐํ๋ฉด ์๋์ PPP, PRP๋ง ๋จ๊ฒ ๋๋ค. ์ด๋ก์จ ์๊ฐ์ ๋ค์ฌ ์ธ์ฌํ๊ฒ ์ถ์ถํ ํ์์์ด ์ค๋ฆฐ๋์ ๋จ์์๋ ๋ชจ๋ ์ฉ์ก์ ํ๊บผ๋ฒ์ ์ญ ์ถ์ถํ๋ฉด ๊ณ ์๋, ๊ณ ๋์ถ์จ์ PRP ์น๋ฃ์ก์ด ๋ง๋ค์ด์ง๋ค. Another method is to first extract the red blood cells and discard them by inserting the needles into the red blood cell layer of the uppermost space of the bottom layer, and then extracting and discarding the upper layer of PPP, leaving only a small amount of PPP and PRP. This ensures high purity and high concentration of PRP treatment solution by extracting all the remaining solution in the cylinder all at once without the need for timely extraction.
์ด๋ ๋ฐฉ๋ฒ์ผ๋ก ํ๋์ง ์ ํ๊ตฌ๋ฅผ ๋ฐฐ์ ํ๊ณ PRP๋ฅผ ์ถ์ถํ๊ธฐ๊ฐ ๋งค์ฐ ์ฉ์ดํ๋ฉฐ ์ด๋ ๊ฒ ์ถ์ถ๋ PRP๋ ์ ํ๊ตฌ๊ฐ ๊ฑฐ์ ์๋ ๊ณ ๋๋์ ์์ํ PRP๊ฐ ๋๋ค.Either way, it is very easy to exclude red blood cells and extract PRP. The extracted PRP becomes high concentration pure PRP with few red blood cells.
๋ณธ ์ฅ์น๋ฅผ ์ด์ฉํ ๋ ๋ ํ๋์ ์ฅ์ ์ PRP์ ๋์ถ์จ์ ์กฐ์ ํ ์ ์๋ค๋ ์ ์ด๋ค. ์์ธต์ PPP๋ฅผ ์ถ์ถํ ๋ ๋จ๊ธฐ๋ PPP์์ ๋ฐ๋ผ PRP์ ๋์ถ์จ์ด ๋ณํ๊ฒ ๋๋ค. ์ ์์ธ์ ํ์ํ ์ซ์๊ฐ 1๋ง์ดํฌ๋ก ๋ฆฌํฐ๋น 10๋ง๊ฐ์์ 20๋ง๊ฐ ์ ๋์ธ๋ฐ PRP์์ ๋ก์ ์น๋ฃํจ๊ณผ๋ฅผ ์ป์ผ๋ ค๋ฉด ํต์ ๊ทธ 5๋ฐฐ์ธ 100๋ง๊ฐ ์ด์์ผ๋ก ๋์ถ๋์ด์ผ ํ๋ค.Another advantage of using this device is the ability to control the concentration of PRP. When extracting the upper PPP, the concentration of PRP changes according to the amount of PPP remaining. The number of platelets in a normal person is about 100,000 to 200,000 per microliter, but the concentration should be concentrated to more than 1 million, which is five times that of PRP.
PPP๋ฅผ ๋จ๊ธฐ์ง ์๊ณ ๊ฑฐ์ ์ ๊ฑฐํ ๋ค ์์ PRP๋ง ์ถ์ถํด ๋ณด๋ฉด ํ์ํ ์ซ์๊ฐ 160๋ง๊ฐ์์ 180๋ง๊ฐ ๊น์ง๋ ์ด๋ฅผ ์ ์์ผ๋ ์ด ๊ฒฝ์ฐ PRP๋ก๋ง ์ด๋ฃจ์ด์ง ์ต์ข ์น๋ฃ์ก์ ๊ทธ ์ฉ๋์ด ๋๋ฌด ์ ์ด ์น๋ฃ ๋ถ์๊ฐ ๋งค์ฐ ์ข์ ๋ถ์์ ํ์ ๋๋ค๋ ๋จ์ ์ด ์๋ค.If only PRP is extracted after almost removing without leaving PPP, the number of platelets can reach 1.6 million to 1.8 million. However, in this case, the final treatment solution composed of PRP is too small, so the treatment area is limited to a very narrow area. .
์ด๋ฌํ ์ด์ ๋ก ์ธํด ์ ์ ์ฉ๋์ PRP ์ฃผ์ ์ก์ ํ๋ณดํ๊ธฐ ์ํ์ฌ ์๋์ PPP๋ฅผ ํฌํจํ์ฌ PRP๋ฅผ ์ถ์ถํ๊ฒ ๋๋๋ฐ ๋์ถ์จ์ ๋ค๋ฅด๊ฒ ์ถ์ถํ๊ณ ์ถ์ผ๋ฉด 2์ฐจ ์์ฌ๋ถ๋ฆฌ ํ ์์ธต๋ถ์ PPP๋ฅผ ์ถ์ถํ ๋, ๋จ๊ธฐ๋ PPP์ ์์ ์กฐ์ ํ๋ฉด ๋๋ค. PPP๋ฅผ ๋ง์ด ๋จ๊ธฐ๋ฉด ์ต์ข ์น๋ฃ์ฃผ์ ์ก์ ์ฉ๋์ ๋์ด๋์ง๋ง ์ ๋์ถ์จ์ PRP๊ฐ ๋๊ณ , PPP๋ฅผ ์ ๊ฒ ๋จ๊ธฐ๋ฉด ์น๋ฃ์ฃผ์ ์ก์ ์ฉ๋์ ์ ์ง๋ง ๊ณ ๋์ถ์จ์ PRP๋ฅผ ์ป์ ์ ์๊ฒ ๋๋ ๊ฒ์ด๋ค. For this reason, PRP is extracted including a small amount of PPP in order to secure an appropriate volume of PRP injection. If you want to extract different concentration rates, adjust the amount of PPP remaining when extracting PPP in the upper layer after the second centrifugation. Just do it. If you leave a lot of PPP, the dose of the final treatment injection will increase, but it will be a low concentration of PRP. If you leave less PPP, you will get a high concentration of PRP, although the dose of treatment injection is small.
์ต์ข ์น๋ฃ์ฃผ์ ์ก ์ฉ๋์ ์ด๋ ์ ๋๋ก ํ ๊ฒ์ธ๊ฐ ํ๋ ๋ฌธ์ ๋ ์์ ํ๋ ์์ฌ๊ฐ ์น๋ฃ ๋ถ์์ ๋ฉด์ ์ ๋ฐ๋ผ ๊ฒฐ์ ํ๊ฒ ๋๋๋ฐ ๋ณธ ์ฅ์น๋ฅผ ์ฌ์ฉํ๊ฒ ๋๋ฉด ์ด์ ๊ฐ์ด ๊ทธ ๋์ถ์จ ์กฐ์ ์ ๋งค์ฐ ๊ฐ๋จํ ์ ์๋ค๋ ์ฅ์ ์ด ์๋ค.The question of how much the final treatment dose is to be determined is determined by the treating physician according to the area of the treatment site. The use of this device has the advantage that the concentration control can be very simple.
๋ณธ์ฒด๋ถ ๋ฐ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด ๋ชจ๋ ํ๋ถ๊ฐ ์ฐ๊ฒฐ๋ถ์๊ฐ ์๋ ๋ฐํํ์ผ๋ก ์ ์๋๋ฏ๋ก ๊ณ ์ํ์ ์ ์ํด ํ์ก ๋์ถ์ ์ผ๋ ค๊ฐ ์๋ ๊ฒฌ๊ณ ํ ๊ตฌ์กฐ๋ก ๋์ด์๋ ๊ฒ๋ ํน์ง์ด๋ค.Both the main body and the secondary centrifuge tube are made of a closed type with no connecting part, so it is also characterized by a robust structure without fear of blood leakage by high-speed rotation.
๋ณธ ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ๋ฅผ ์ด์ฉํ์ฌ PRP๋ฅผ ์ถ์ถํ๊ฒ ๋๋ฉด ๋ค์๊ณผ ๊ฐ์ ์ด์ ์ด ์๋ค.Extracting PRP using the plasma extraction kit according to the present embodiment has the following advantages.
์ฒซ์งธ ๋ชจ์ธ๊ด์ด ์ํ์ ํ ์ดํผ๋ถ๋ฅผ ํ์ฑํ๊ณ ์ค์๋ถ๋ถ์ด ๊ธฐ๋ค๋๊ฒ ํ์ฑ๋์ด ์์ด ์ ํ๊ตฌ์์ ๋ณํ์ ๋ฐ๋ฅธ ํธ์ฐจ๋ฅผ ๋๋ถ๋ถ ์์ฉํ ์ ์์ด ๋ณ๋์ ์กฐ์์ด ํ์์๊ธฐ ๋๋ฌธ์ PRP๋ฅผ ์ถ์ถํ๋ ์๊ฐ์ด ๋จ์ถ์ด ๋๋ค.First, the capillary is tapered up and down, and the central part is elongated to accommodate most of the variation due to the change in red blood cell volume, so that no time is required to extract PRP.
๋์งธ ์ ํ๊ตฌ๋์ ๋ณํ๊ฐ ํธ์ฐจ๋ฅผ ๋ฒ์ด๋๊ฒ ๋์ด PRP๊ฐ ๊ธฐ๋ค๋๊ฒ ํ์ฑ๋ ๋ชจ์ธ๊ด์ ์์ฉ๋ฒ์๋ฅผ ์ด๊ณผํ๊ฒ ๋๋ฉด ์ค๋ฆฐ๋ ๋ฎ๊ฐ๋ฅผ ๋๋ ค ๋์ด ์กฐ์ ์ ํ์ฌ ์ถ์ถํ ์ ์๋๋ก 2์ฐจ ๋ณด์ ์ฅ์น๊ฐ ์๋ค. ์ด๋์๋ ๋ชจ์ธ๊ด์ด ๊ธธ๋ฏ๋ก ์์ ์์ ์กฐ์ ์ค์ฐจ ๋ฒ์๊ฐ ๋์ด ์ถ์ถ์ด ์ฉ์ดํ๊ณ ๋น ๋ฅด๋ค๋ ์ฅ์ ์ด ์๋ค.Second, when the change in the red blood cell volume is out of the deviation and the PRP exceeds the receiving range of the long capillary tube, there is a secondary correction device that can be extracted by adjusting the height by turning the cylinder cover. At this time, since the capillary is long, there is an advantage that the operator's operating range is wide and easy to extract.
์ ์งธ 1์ฐจ ์์ฌ๋ถ๋ฆฌ ํ PRP, PPP๋ฅผ ์ถ์ถํ ๋ ๊ฐ์ด ํฌํจ๋์ด ์ถ์ถํ ์ ๋ฐ์ ์๋ ์๋์ ์ ํ๊ตฌ๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ํตํด ๋ฐฐ์ ํ ์ ์์ผ๋ฏ๋ก ์ ํ๊ตฌ๊ฐ ํฌํจ๋์ง ์๋ ์๋๋์ PRP๋ฅผ ์ถ์ถํ ์ ์๋ค.Third, a small amount of erythrocytes included in the extraction of PRP and PPP after the first centrifugation can be excluded through the second centrifuge tube, so that PRP can be extracted without high erythrocytes.
๋ท์งธ ๊ณ ์๋ 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด์ ์ฌ์ฉํ๊ฒ ๋๋ฉด ์์ ํ ๋๋ก PRP์ ๋์ถ์จ ์กฐ์ ์ด ๊ฐ๋ฅํ๋ค.The fourth designed second centrifuge tube can be used to control the concentration of PRP as described above.
๋ค์ฏ์งธ ๋ณธ์ฒด๋ถ, 2์ฐจ ์์ฌ๋ถ๋ฆฌ๊ด ๋ชจ๋ ๋๊ป์ ์ด์ง ์๊ณ ์กฐ์์ด ๊ฐ๋ฅํ๋๋ก ์ค๊ณ๋์ด ์์ด ์ธ๋ถ ๊ฐ์ผ์ ๋ํด ์์ ํ๋ค.Fifth, the main body and the second centrifuge tube are designed to be operated without opening the lid, which is safe against external infection.
์ฌ์ฏ์งธ ์์ฌ๋ถ๋ฆฌ ๋ ๊ฐ์ฅ ๋ง์ ํ์ถ ์๋ ฅ์ด ๊ฑธ๋ฆฌ๋ ์์ฌ๋ถ๋ฆฌ๊ด์ ํ๋ถ๊ฐ ์ฐ๊ฒฐ๋ถ์๊ฐ ์๋ ๋ฐํํ์ผ๋ก ๋์ด์์ด ํ์ก ๋์ถ์ ์ํ์ด ์๋คSixth centrifugation, the lower part of the centrifuge tube, which has the highest escape pressure during the centrifugation, is a sealed type with no connection, so there is no risk of blood leakage
์ผ๊ณฑ์งธ ํ๋ถ์ ๋์ด ์กฐ์ ์ฉ ๋์ฌ๊ฐ ๋ฌ๋ ค์๋ ๊ธฐ์กด์ ํ์ก ๋ถ๋ฆฌ ์ฅ์น์ ๋นํด ๊ตฌ์กฐ๊ฐ ๋จ์ํ์ฌ ์ ์ ๋น์ฉ์ผ๋ก ์ ์์ด ๊ฐ๋ฅํ๋ค.The seventh lower part is simpler in structure compared to the existing blood separation device with a height adjusting screw, and thus can be manufactured at a low cost.
<์ค์์ 2><Example 2>
๋ 14 ๋ด์ง ๋ 22๋ ๋ณธ ๋ฐ๋ช
์ ์ 2 ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ(100)๋ฅผ ๋ํ๋ด๋ ๋๋ฉด์ด๋ค. 14 to 22 are diagrams showing the
๋ 14 ๋ด์ง ๋ 22์ ๋ํ๋ธ ๋ฐ์ ๊ฐ์ด, ๋ณธ ์ค์์์ ์ํ ํ์ฅ์ถ์ถํคํธ๋ ๋ณธ์ฒด๋ถ(110)์, ๋ฎ๊ฐ๋ถ(120)์, ํ์ก์ ์ฅ๋ถ(130)์, ๊น๋๊ธฐ๋ถ(140, 141)์, ์ฐ๊ฒฐ๋ ๊ฐ๋ถ(150)์, ๊ฐํ ์บก(160)์ ํฌํจํ๋ค. As shown in Figures 14 to 22, the plasma extraction kit according to the present embodiment is the
์๊ธฐ ๋ณธ์ฒด๋ถ(110)๋ ์๋จ์ด ๊ฐ๊ตฌ๋๊ณ ํ๋จ์ด ํ์๋์ด ์๋ ์ํตํ ํ์์ผ๋ก ํ์ฑ๋์ด ์๋ค. ์๊ธฐ ๋ณธ์ฒด๋ถ(110)์ ์ฌ์ง์ ํนํ ํ์ ๋์ง๋ ์์ผ๋, ๋ณธ ์ค์์์ ์์ด์๋ ์ ์กฐ๋น์ฉ์ด ์ ๋ ดํ๊ณ ์ ์กฐ๊ฐ ์ฉ์ดํ ํ๋ผ์คํฑ ์ฌ์ง์ธ ๊ฒ์ ์๋ก ํ๋ค. The
์๊ธฐ ๋ณธ์ฒด๋ถ(10)์ ๋ด๋ถ๋ฉด์ ์ค์๋ถ๋ถ์๋ ์ฒด๊ฒฐํ(110b)์ด ํ์ฑ๋๋ค. ์๊ธฐ ์ฒด๊ฒฐํ(110b)์ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด์ธก๋ฉด์์ ์ค๋ชฉํ๊ฒ ์ ๊ฐ๋์ด ํ์ฑ๋๋ฉฐ, ์๊ธฐ ๋ณธ์ฒด๋ถ ๋ด์ธก๋ฉด์ ์ ์ฒด ๋๋ ์ ๊ฑธ์ณ ํ์ฑ๋์ง ์๊ณ ์ผ์ ํ ํญ์ ๊ตฌ๋นํ๋๋ก ํ์ฑ๋๋ค. A
์๊ธฐ ์ฒด๊ฒฐํ(110b)์ ํ์ฑํจ์ผ๋ก์จ ์๊ธฐ ์ฒด๊ฒฐํ(110b)์ ํ๋ถ์ ํ์ฑ๋๋ ๋จํฑ(110a)์ ํ์ ํ๋ ๊น๋๊ธฐ๋ถ๊ฐ ์น์ด๋์ฌ์ง๋ฉฐ, ํ์ ํ๋ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ์ด๋์ ์ํ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ํ์ ์ด ์๊ธฐ ์ฒด๊ฒฐํ์ ํญ๋งํผ ํ์ ๋๋๋ก ๊ตฌ์ฑ๋๋ค. By forming the
์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๋ถ์๋ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ํ์ ํ๋ ๋ฎ๊ฐ๋ถ์์ ์ฌ์ด์ ํจํน์ด๋ O๋ง ๋ฑ์ ๋ฐ๋ด๋ถ์ฌ(110c)๊ฐ ๊ฐ์ฌ๋์ด ์๊ธฐ ๋ณธ์ฒด๋ถ๋ฅผ ๋ฐํํ๋๋ก ๊ตฌ์ฑ๋๋ค. An upper portion of the main body portion is provided to seal the main body portion with a sealing
์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ ํ๋จ์๋ ํ์ก์ ์ฅ๋ถ(130)๊ฐ ์์ฉ๋๋ค. ์๊ธฐ ํ์ก์ ์ฅ๋ถ๋ ์๋จ์ด ๊ฐ๊ตฌ๋๊ณ ํ๋จ์ด ํ์๋ ์ํตํ์์ผ๋ก ํ์ฑ๋๋ฉฐ ์๊ธฐ ๋ณธ์ฒด๋ถ ๋ด๋ถ์ ๊ธฐ๋ฐํ๊ฒ ์์ฉ๋๋ค. ์๊ธฐ ํ์ก์ ์ฅ๋ถ(130)์๋ ์ฃผ์
๋ ํ์ก์ ์์ฌ๋ถ๋ฆฌ ํ์ ํ์ก์ ์ ํ๊ตฌ ๋ถ๋ถ์ด ์์ฉ๋๋ค. The
์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ์์ ์๊ธฐ ํ์ก์ ์ฅ๋ถ์ ์๋ถ์๋ ๊น๋๊ธฐ๋ถ(140, 141)๊ฐ ์ค์น๋๋ค. ์๊ธฐ ๊น๋๊ธฐ๋ถ(140, 141)๋ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ ์ค์๋ถ๋ถ์ ์ฒด๊ฒฐ๋๋ฉฐ, ๋ 15 ๋ฐ ๋ 16์ ๋ํ๋ธ ๋ฐ์ ๊ฐ์ด, ์ค์๋ถ์ ์ง๊ฒฝ์ด ์๊ณ ์๋จ๋ถ๋ ์ค์๋ถ๋ฅผ ํฅํ์ฌ ์ง๊ฒฝ์ด ์ ์ฐจ ๊ฐ์ํ๋ ํ
์ดํผ ํ์์ผ๋ก ํ์ฑ๋๋ค.
์ด๋ก์จ, ์ ํ๊ตฌ ์์ธต๋ฉด๊ณผ PRP ํ์ธต๋ฉด์ ๊ฒฝ๊ณ๋ถ์์์๋ ์ ํ๊ตฌ์ ํ์ํ ๋ ์ข ๋ฅ์ ํ๊ตฌ๊ฐ ์๋ก ์ฝํ์๋๋ฐ ์ด ๋ถ๋ถ์ ์ถ์ถํ๋ ๋จ๊ณ์์ ๊ฐ๋ฅํ ํ ์ ํ๊ตฌ๋ฅผ ํฌํจํ์ง ์๊ณ ์ถ์ถํ๊ธฐ ์ํด ์์ ์๊ฐ์ด ๋ง์ด ๊ฑธ๋ฆฌ๊ฒ ๋๋ฉฐ, ์กฐ์์์ ์๋ จ๋์ ๋ฐ๋ผ์ ์ถ์ถ์ก์ ํ์ง์ ํธ์ฐจ๊ฐ ์๊ธฐ๊ฒ ๋์ง๋ง, ๋ณธ ๋ฐ๋ช ์ ์ํ๋ฉด ์์ฌ๋ถ๋ฆฌํ์ ํ์ก์ฑ๋ถ ์ค ๋ค๋์ธ ์ ํ๊ตฌ๋ ์๊ธฐ ํ์ก์ ์ฅ๋ถ์ ์์ฉ๋๊ณ , ์๋์ธ PRP๋ ์ง๊ฒฝ์ด ์์ ๊น๋๊ธฐ๋ถ์ ์ค์์ ์์ฉํ ์ ์์ผ๋ฉฐ, PRP๊ฐ ์๋์ด๋ผ ํ๋๋ผ๋ ์ง๊ฒฝ์ด ์์ ๊น๋๊ธฐ๋ถ์ ์ค์๋ถ๋ถ์ ์์ฉ๋๋ฏ๋ก ์๋ ๋์ ๊ณ ๋๋์ PRP๋ฅผ ์ฉ์ดํ๊ฒ ์ถ์ถํ ์ ์๊ณ , ์ถ์ถ ๊ณผ์ ์์ ์ ํ๊ตฌ๋ฅผ ๊ฑฐ์ ๋ฐฐ์ ํ๊ณ ์ถ์ถํ ์ ์๋ค. As a result, red blood cells and platelets are intertwined in the boundary area between the upper surface of the red blood cells and the lower surface of the PRP. In the step of extracting these parts, it takes a long time to extract the red blood cells as much as possible. According to the present invention, the quality of the extract may vary, but according to the present invention, after centrifugation, a large amount of red blood cells in the blood component is accommodated in the blood storage unit, and a small amount of PRP can be accommodated in the center of the funnel having a small diameter. Even if a small amount of PRP is accommodated in the central portion of the funnel having a small diameter, it is possible to easily extract high-purity high concentrations of PRP, and almost eliminate red blood cells in the extraction process.
๋ณธ ์ค์์์ ์์ด์, ์๊ธฐ ๊น๋๊ธฐ๋ถ๋ ํ๋์ ๋จ์์ฒด๋ก ํ์ฑ๋ ์๋ ์์ผ๋, ํ๋ผ์คํฑ ์ฌ์ง๋ก ์ฌ์ถ์ฑํํ ๋์ ์ง๊ฒฝ์ด ์์ ์ค์๋ถ์ ๊ฒฝ์ฐ ๊ธฐํฌ์ ๋ฐ์ ๋ฑ ๋ถ๋์ด ๋ฐ์ํ์ฌ ๋ถ๋์ด ๋ฐ์ํ ์ผ๋ ค๊ฐ ์์ผ๋ฏ๋ก, ๋ดํต(141)๊ณผ ์ธํต(140)์ผ๋ก ๋ถ๋ฆฌ๋์ด ํ์ฑ๋๋ ๊ฒ์ ์๋ก ํ๋ค. In the present embodiment, the funnel portion may be formed as one unit, but in the case of injection molding of plastic material, the inner portion of the central portion having a small diameter may cause a defect such as the generation of bubbles due to the occurrence of a defect. For example, it is formed separately from the
์๊ธฐ ๋ดํต(141)์ ์ค์๋ถ๋ถ์ ์ง๊ฒฝ์ด ์๊ณ ์๋จ๋ถ๋ ์ค์๋ถ๋ฅผ ํฅํ์ฌ ์ง๊ฒฝ์ด ์ ์ฐจ ๊ฐ์ํ๋ ํ
์ดํผ ํ์์ผ๋ก ํ์ฑ๋๋ค. The
์๊ธฐ ์ธํต(140)์ ์ํ๋ถ๊ฐ ๊ฐ๊ตฌ๋ ์ค๊ณต์ ์ํตํ ํ์์ผ๋ก ํ์ฑ๋์ด ์์ผ๋ฉฐ, ์๊ธฐ ์ธํต์ ํ๋จ๋ถ๋ ๋ด์ธก์ผ๋ก ์ฐ์ฅ๋์ด ๋์ถ๋๋๋ก ํ์ฑ๋๋ฉฐ, ๋์ถ๋ ๋ถ๋ถ์ ์๋จ์๋ ์์ฐฉํ(140b)์ด ๋ง๋ จ๋๋ค. ์๊ธฐ ์์ฐฉํ(140b)์๋ ์๊ธฐ ๋ดํต์ ํ
์ดํผ ํ์์ ํ๋จ ๋๋จ๋ถ๊ฐ ์ฝ์
๋์ด ์์ฐฉ๋์ด ์๊ธฐ ๋ดํต๊ณผ ์๊ธฐ ์ธํต์ด ์ผ์ฒด๋ก ์ฐ๊ฒฐ๋๋๋ก ๊ตฌ์ฑ๋๋ค. The
์๊ธฐ ์ธํต(140)์๋ ์๊ธฐ ์ธํต์ ์ธ๋ถ๋ฉด์ผ๋ก๋ถํฐ ์๊ธฐ ์ธํต์ ๊ธธ์ด๋ฐฉํฅ์ ๋ฐ๋ผ ์ธ์ธก์ผ๋ก ๋์ถ๋์ด ์ฒด๊ฒฐ๋๊ธฐ(140a)๊ฐ ํ์ฑ๋์ด ์๋ค. ์๊ธฐ ์ฒด๊ฒฐ๋๊ธฐ(140a)๋ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์ฒด๊ฒฐํ(110b)์ ์ฝ์
๋๋ค. The
๋ํ, ์๊ธฐ ์ธํต(140)์ ์๋จ๋ถ์๋ ๊ฑธ๋ฆผ๊ณ ์ ํ(140c)์ด ํ์ฑ๋๋ค. ์๊ธฐ ๊ฑธ๋ฆผ๊ณ ์ ํ(140c)์ ์๊ธฐ ์ธํต์ ์๋ถ๋๋จ์ผ๋ก๋ถํฐ ์ญT์ ํ์์ผ๋ก ์ ๊ฐ๋์ด ํ์ฑ๋๋ค. ์๊ธฐ ๊ฑธ๋ฆผ๊ณ ์ ํ(140c)์๋ ํ์ ํ๋ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ์ 1 ๋ ๊ฐ๋ถ๊ฐ ์ฝ์
๋์ด ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ์๊ธฐ ์ธํต์ด ์ผ์ฒด๋ก ๊ฑฐ๋ํ๋๋ก ๊ตฌ์ฑ๋๋ค. In addition, the upper end of the
์์ ํ ๊ตฌ์ฑ์ ์ํ์ฌ, ์๊ธฐ ์ธํต์ ์๋จ๋ถ๋ถ์ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ๊ฐ ์ฐ๊ฒฐ๋์ด ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ๊ฐ ํ์ ํ๋ ๋ฐ์ ๊ฐ์ด, ๋ฎ๊ฐ๋ถ์ ๋์ฌ์ฒด๊ฒฐ๋์ด ๋ฎ๊ฐ๋ถ๋ฅผ ํ์ ์ํค๋ฉด ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ ๋ฐ ์ด์ ์ฐ๊ฒฐ๋ ์ธํต์ ํ์ ํ๊ฒ ๋๋ค. ์ด ๋, ์๊ธฐ ์ธํต์ ์๊ธฐ ์ฒด๊ฒฐ๋๊ธฐ๋ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์ฒด๊ฒฐํ์ ์ฝ์ ๋ ์ํ์์ ์๊ธฐ ์ฒด๊ฒฐํ์ ํญ๋งํผ ํ์ ๋๋ค๊ฐ ์๊ธฐ ์ฒด๊ฒฐํ์ ๋๋จ์ ์ํด ์ ์ง๋๊ณ , ์ด์ ๋ฐ๋ผ ํ์ ์ด ์ ์ง๋ ์๊ธฐ ์ธํต์ ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ๊ณ ์ ๋ ์ํ์์ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ํ์ ์ ์ํด ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ์์ ์๋ถ ๋๋ ํ๋ถ๋ก ์์น๊ฐ ์ด๋ํ ์ ์๋๋ก ๊ตฌ์ฑ๋๋ค. By the above-described configuration, when the connection blade is connected to the upper end of the outer cylinder, and the connection blade is screwed to the cover portion as described below, when the cover portion rotates, the connection blade portion and the outer cylinder connected thereto are rotated. At this time, the fastening protrusion of the outer cylinder is rotated by the width of the fastening groove in the state inserted into the fastening groove of the main body portion is blocked by the end of the fastening groove, thereby the outer cylinder is stopped rotation is the connection blade It is configured to move the position from the inside of the main body portion to the upper or lower by the rotation of the cover portion in a fixed state.
์ด๋ก์จ, ์ฌ๋์ ๋ฐ๋ผ ์ ํ๊ตฌ์ ์์ด ๋ค๋ฅด๋ค ํ๋๋ผ๋ ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ ๋ฐ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ๊ตฌ์ฑ์ ์ํด ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์์น๋ฅผ ์กฐ์ ํ ์ ์์ผ๋ฏ๋ก, ์๊ธฐ ๊น๋๊ธฐ๋ถ์ PRP๋ฅผ ์ ํํ๊ฒ ์์น์ํฌ ์ ์๊ณ , ์ด๋ก์จ ์๋์ธ PRP๋ ์ง๊ฒฝ์ด ์์ ๊น๋๊ธฐ๋ถ์ ์ค์์ ์์ฉํ ์ ์์ผ๋ฉฐ, PRP๊ฐ ์๋์ด๋ผ ํ๋๋ผ๋ ์ง๊ฒฝ์ด ์์ ๊น๋๊ธฐ๋ถ์ ์ค์๋ถ๋ถ์ ์์ฉ๋๋ฏ๋ก ์๋ ๋์ ๊ณ ๋๋์ PRP๋ฅผ ์ฉ์ดํ๊ฒ ์ถ์ถํ ์ ์๊ณ , ์ถ์ถ ๊ณผ์ ์์ ์ ํ๊ตฌ๋ฅผ ๊ฑฐ์ ๋ฐฐ์ ํ๊ณ ์ถ์ถํ ์ ์๋ค. Thus, even if the amount of red blood cells differs from person to person, since the position of the funnel can be adjusted by the configuration of the connecting wing part and the funnel part, the PRP can be accurately positioned in the funnel part, whereby a small amount of PRP has a diameter. It can be accommodated in the center of a small funnel, and even if a small amount of PRP is accommodated in the center of a small funnel, it can easily extract high-purity PRP with high purity and almost eliminate red blood cells in the extraction process. .
์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ(150)๋ ์ผ์ธก์ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์ฒด๊ฒฐ๋๊ณ , ํ์ธก์ ์๊ธฐ ์ธํต์ ์ฒด๊ฒฐ๋๋ค. The
์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ(150)๋, ์๊ธฐ ์ธํต๊ณผ ์ฒด๊ฒฐ๋๋ ๋ถ๋ถ์ ์ 1 ๋ ๊ฐ๋ถ(152)๊ฐ ํ์ฑ๋๊ณ , ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์ฒด๊ฒฐ๋๋ ์ธก์ ์ฐ๊ฒฐ๋๊ธฐ(151)๊ฐ ํ์ฑ๋๋ค. The connecting
์๊ธฐ ์ 1 ๋ ๊ฐ๋ถ(152)๋ ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ํญ์ผ๋ก๋ถํฐ ์ธ์ธก์ผ๋ก ๋์ถ๋์ด T์ ํ์์ผ๋ก ํ์ฑ๋๋ฉฐ, ์๊ธฐ ๊ฑธ๋ฆผ๊ณ ์ ํ(140c)์ ์ฝ์
๋๋ค. ์๊ธฐ ์ฐ๊ฒฐ๋๊ธฐ(151)๋ ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ๋ณธ์ฒด๋ก๋ถํฐ ๋ด์ธก, ์ฆ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์ค์์ธก์ ํฅํ์ฌ ์ผ์ ๊ธธ์ด ๋์ถ๋๋๋ก ํ์ฑ๋๋ฉฐ, ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ํ์ฑ๋ ๋์ฌ์ฐ์ ์ฒด๊ฒฐ๋๋๋ก ๊ตฌ์ฑ๋๋ค. The
์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๋ถ์๋ ๋ฎ๊ฐ๋ถ(120)๊ฐ ๋ง๋ จ๋๊ณ , ์๊ธฐ ๋ฎ๊ฐ๋ถ(120)๋ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๋จ์ ํ์ํ๋๋ก ๊ตฌ์ฑ๋๋ค. ย The
์๊ธฐ ๋ฎ๊ฐ๋ถ(120)๋ ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๋จ์ ๋ฎ๋ ์๋ถ๋ฉด๊ณผ ์๊ธฐ ์๋ถ๋ฉด์ผ๋ก๋ถํฐ ์์ง ํํฅ์ผ๋ก ์ฐ์ฅ๋์ด ํ์ฑ๋์ด ์๊ธฐ ๋ณธ์ฒด๋ถ์ ๋ด๋ถ์ ์ฝ์
๋๋ ์ฐ์ฅ๋ถ๋ฅผ ๊ตฌ๋นํ๋ฉฐ, ์๊ธฐ ์ฐ์ฅ๋ถ์ ์ธ์ฃผ๋ฉด์๋ ๋์ฌ์ฐ(121)์ด ํ์ฑ๋์ด ์๊ณ ์๊ธฐ ๋์ฌ์ฐ์๋ ์๊ธฐ ์ฐ๊ฒฐ๋ ๊ฐ๋ถ์ ์ฐ๊ฒฐ๋๊ธฐ๊ฐ ๋์ฌ๊ฒฐํฉ๋๋๋ก ๊ตฌ์ฑ๋์ด ์๋ค. The
์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์๊ธฐ ์๋ถ๋ฉด๊ณผ ์๊ธฐ ์ฐ์ฅ๋ถ ์ฌ์ด์๋ ์ง์ง๋๊ธฐ(122)๊ฐ ํ์ฑ๋์ด ์๊ธฐ ์๋ถ๋ฉด์ ํ๋ถ์ ์๊ธฐ ์ง์ง๋๊ธฐ ์ฌ์ด์ ์๊ธฐ ๋ฐ๋ด๋ถ์ฌ(110c)๋ฅผ ์ค์นํ์ฌ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์๊ธฐ ๋ณธ์ฒด๋ถ ์ฌ์ด๋ฅผ ์์ ์ ์ผ๋ก ๋ฐ๋ดํ ์ ์๋๋ก ๊ตฌ์ฑ๋๋ค.A
์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์๋ถ๋ฉด ์ค์์๋ ์ฒด๊ฒฐํ(123)์ด ํ์ฑ๋๋ฉฐ, ์๊ธฐ ์ฒด๊ฒฐํ(123)์๋ ํ์ ํ๋ ๊ฐํ ์บก(160)์ด ๊ฐํ๊ฐ๋ฅํ๊ฒ ์ฝ์
๋๋ค. ๋ํ, ์๊ธฐ ๋ฎ๊ฐ๋ถ์๋ ์๊ธฐ ์ฒด๊ฒฐํ์ ์ค์์ ํฅํ์ฌ ๋์ถ๋๋ ๋์ถ๋ถ(124)๊ฐ ํ์ฑ๋๋ค. ์๊ธฐ ๋์ถ๋ถ์๋ ํ์ ํ๋ ๊ฐํ ์บก์ ๊ฑธ๋ฆผ๋๊ธฐ๊ฐ ๊ฑธ๋ฆผ๊ณ ์ ๋์ด, ์๊ธฐ ๊ฐํ ์บก์ ๊ฐํ์์ ์๊ธฐ ๊ฐํ ์บก์ด ์๊ธฐ ๋ฎ๊ฐ๋ถ๋ก๋ถํฐ ์ดํ๋์ง ์๊ณ ์์ ์ ์ผ๋ก ๊ฐํ๋๋๋ก ๊ตฌ์ฑ๋๋ค. A
์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์ฒด๊ฒฐํ(123)์๋ ๊ฐํ ์บก(160)์ด ์ฝ์
๋๋ค. ์๊ธฐ ๊ฐํ ์บก(160)์ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ๊ฐํ๊ฐ๋ฅํ๊ฒ ์ฒด๊ฒฐ๋๋ค. The opening and
์๊ธฐ ๊ฐํ ์บก(160)์ ์ฃผ์
ํ(161)๊ณผ, ๊ฑธ๋ฆผ๋๊ธฐ(162a, 162b)์, ๋ฐํ๋ง(163)์ ๊ตฌ๋นํ๋ค. ์๊ธฐ ์ฃผ์
ํ(161)์ ํ์๋ก๋ถํฐ ์ถ์ถํ ํ์ก์ ์ฃผ์
ํ๋ ์ฃผ์ฌ๊ธฐ์ ์ฃผ์ฌ๋ฐ๋์ด ์ฝ์
๋ ์ ์๋๋ก ์๊ธฐ ๊ฐํ ์บก์ ๋ณธ์ฒด์ ์ผ์ธก๋ฉด์ ํ์ฑ๋๋ค. The opening /
์๊ธฐ ๊ฑธ๋ฆผ๋๊ธฐ๋ ์๋ถ ๊ฑธ๋ฆผ๋๊ธฐ(162b)์, ํ๋ถ ๊ฑธ๋ฆผ๋๊ธฐ(162a)๋ก ๊ตฌ์ฑ๋๋ฉฐ, ์๊ธฐ ๊ฐํ ์บก์ ๋ณธ์ฒด๋ก๋ถํฐ ์ธ์ธก์ผ๋ก ๋์ถ๋์ด ํ์ฑ๋๋ค. ์๊ธฐ ๊ฐํ ์บก์ ๊ฐ๋ฐฉํ ๋์๋ ์๊ธฐ ํ๋ถ ๊ฑธ๋ฆผ๋๊ธฐ(162a)๊ฐ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์๊ธฐ ๋์ถ๋ถ์ ํ๋ถ๋ฉด์ ๋ง๋ฟ์ ๊ฑธ๋ฆผ๊ณ ์ ๋๋ฉฐ, ์๊ธฐ ๊ฐํ ์บก์ ๋ฐํํ ๋์๋ ์๊ธฐ ์๋ถ ๊ฑธ๋ฆผ๋๊ธฐ(162b)๊ฐ ์๊ธฐ ๋์ถ๋ถ์ ์๋ถ๋ฉด์ ๋ง๋ฟ์ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์๊ธฐ ๊ฐํ ์บก ์ฌ์ด๋ฅผ ๋ฐ๋ดํ๋๋ก ๊ตฌ์ฑ๋๋ค. The locking protrusion is composed of an
์๊ธฐ ๋ฐํ๋ง(163)์ ์๋ถ๋ฉด ์ค์์ ํ์ฑ๋ ๊ฐ๊ตฌ๋ฅผ ํ์ํ๋ฉฐ, ์์ฌ๋ถ๋ฆฌ๋ ํ์ก์ ๋คํ์ํ ํ์ฅ์ ์ถ์ถํ๊ธฐ ์ํ ์ฃผ์ฌ๊ธฐ๊ฐ ์ฉ์ดํ๊ฒ ์ฝ์
๋ ์ ์๋ ์ฌ์ง๋ก ํ์ฑ๋๋ ๊ฒ์ด ๋ฐ๋์งํ๋ค. The sealing
์์ ํ ๊ตฌ์ฑ์ ๊ฐ์ง๋ ๋ณธ ๋ฐ๋ช ์ ํ์ฅ์ถ์ถํคํธ๋ฅผ ์ฌ์ฉ์์ ๋ํ์ฌ, ๋ 9๋ฅผ ์ฐธ์กฐํ์ฌ ์ค๋ช ํ๋ค. An example of using the plasma extraction kit of the present invention having the above-described configuration will be described with reference to FIG.
์ฐ์ , ๊ณต์ฅ์์ ์ ์กฐ๋ ๋ณธ ๋ฐ๋ช ์ ์ํ ํ์ฅ์ถ์ถํคํธ๋ฅผ ์๊ธฐ ๋ฎ๊ฐ๋ถ๋ก๋ถํฐ ์๊ธฐ ๊ฐํ ์บก์ ๊ฐ๋ฐฉํ ์ํ๋ก ํฌ์ฅ์ง์ ๋ฐ๋ดํ๋ค. ์ฌ๊ธฐ์, ์๊ธฐ ํฌ์ฅ์ง๋ ์ผ๋ฉด์ด ์๋ ๊ฐ์ค๊ฐ ์นจํฌํ ์ ์๋ ํน์ ์ข ์ด์ฌ์ง๋ก ๊ตฌ์ฑ๋๋ ๊ฒ์ด ๋ฐ๋์งํ๋ค. First, the plasma extraction kit according to the present invention manufactured in a factory is sealed in a wrapping paper with the opening and closing cap open from the cover part. Here, the wrapping paper is preferably made of a special paper material that one side can penetrate the disinfection gas.
์๊ธฐ ํฌ์ฅ์ง์ ๋ฐ๋ด๋ ์ํ์์ ์๊ธฐ ํ์ฅ์ถ์ถํคํธ๋ฅผ EO๊ฐ์ค ๋ฑ์ ์๋ ๊ฐ์ค๋ฅผ ์ฌ์ฉํ์ฌ ์๋ ํ๋ฉด, ํฌ์ฅ์ง๋ฅผ ์นจํฌํ ์๋ ๊ฐ์ค๋ ์๊ธฐ ๊ฐํ ์บก์ ์ฃผ์ ํ์ ํตํด ํ์ฅ์ถ์ถํคํธ์ ๋ด๋ถ๋ก ์ฃผ์ ๋์ด ์๋ ์ด ์ฉ์ดํ๊ฒ ์ด๋ฃจ์ด์ง๋ค. When the plasma extraction kit is sterilized using a disinfection gas such as EO gas in the sealed state, the disinfection gas penetrating the packaging is injected into the plasma extraction kit through the injection hole of the opening and closing cap to facilitate disinfection. It is done.
๊ทธ๋ฐ ๋ค์, ์ฌ์ฉ์์ ํฌ์ฅ์ง๋ฅผ ๋ฒ๊ฒจ๋ธ ํ, ํ์๋ก๋ถํฐ ์ถ์ถํ ํ์ก์ด ๋ด๊ฒจ ์๋ ์ฃผ์ฌ๊ธฐ์ ์ฃผ์ฌ๋ฐ๋์ ์๊ธฐ ๊ฐํ ์บก์ ์ฃผ์ ํ์ ํตํด ์ฃผ์ ํ๋ค. Then, after use, the wrapping paper is peeled off, and the needle of the syringe containing the blood extracted from the patient is injected through the injection hole of the opening / closing cap.
ํ์ก ์ฃผ์ ์ด ์๋ฃ๋๋ฉด, ์๊ธฐ ๊ฐํ ์บก์ ๋๋ฌ ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ์๊ธฐ ๊ฐํ ์บก์ ๋ฐ๋ดํจ์ผ๋ก์จ ํ์ฅ ์ถ์ถ์ ์ํ ์ค๋น๊ฐ ์๋ฃ๋๋ค. When blood injection is completed, pressing the opening and closing cap seals the lid and the opening and closing cap to complete preparation for plasma extraction.
๊ทธ๋ฐ ๋ค์, ์๊ธฐ ํ์ฅ์ถ์ถํคํธ๋ฅผ ์์ฌ๋ถ๋ฆฌ๊ธฐ์ ์ํด ์์ฌ๋ถ๋ฆฌํ ํ, ํ์ฅ์ฑ์ทจ์ฉ ์ฃผ์ฌ๊ธฐ๋ฅผ ์๊ธฐ ๊ฐํ ์บก์ ๋ฐํ๋ง์ ํตํด ์ฃผ์ ํ ํ, ์ฃผ์ฌ๋ฐ๋์ ๋๋จ์ ์๊ธฐ ๊น๋๊ธฐ๋ถ์ ์ง๊ฒฝ์ด ์์ ์ค์๋ถ๊น์ง ์ฝ์ ํ์ฌ PRP๋ฅผ ๊ฐ๋จํ๊ฒ ์ถ์ถํ ์ ์๋ค. Then, the plasma extraction kit is centrifuged by a centrifuge, and a plasma collection syringe is injected through the sealing membrane of the opening / closing cap. Then, the end of the needle is inserted into the center of the small diameter of the funnel to insert the PRP. It can be extracted simply.
์ด๋ก์จ, ์๊ธฐ ๋ฎ๊ฐ๋ถ์ ๊ฐํ๊ฐ ๊ฐ๋ฅํ ๊ฐํ ์บก์ ์ค์นํ๊ณ ๊ฐํ ์บก์ ์ฃผ์ ํ์ ๊ตฌ๋นํจ์ผ๋ก์จ, ์๊ธฐ ๋ณธ์ฒด๋ถ์ ์๊ธฐ ๋ฎ๊ฐ๋ถ๋ฅผ ์ฒด๊ฒฐํ ์ํ๋ก ์๊ธฐ ํ์ฅ์ถ์ถํคํธ๋ฅผ ํฌ์ฅ์ง๋ก ๋ฐ๋ดํ๋๋ผ๋ ์๊ธฐ ํ์ฅ์ถ์ถํคํธ๋ฅผ EO๊ฐ์ค์ ์ํด ์๋ ํ ๋์ ์๋ ๊ฐ์ค๊ฐ ์๊ธฐ ๊ฐํ ์บก์ ์ฃผ์ ํ์ ํตํด ์๊ธฐ ํ์ฅ์ถ์ถํคํธ์ ๋ด๋ถ๋ก ํฌ์ ๋ ์ ์์ผ๋ฏ๋ก ์๋ ์ ์ฉ์ดํ๊ฒ ํ ์ ์๋ค. Thus, by installing an opening and closing cap that can be opened and closed on the cover portion and the injection hole in the opening and closing cap, even if the plasma extraction kit is sealed with a wrapping paper in the state that the cover portion is fastened to the EO gas When disinfecting by the disinfection gas can be introduced into the plasma extraction kit through the injection hole of the opening and closing cap can facilitate disinfection.
๋ํ, ์ฌ์ฉ์์ ์๊ธฐ ๊ฐํ ์บก์ ๊ฐ๋ฐฉํ ํ ์๊ธฐ ๊ฐํ ์บก์ ์ฃผ์ ํ์ ์ฃผ์ฌ๊ธฐ์ ๋ฐ๋์ ์ฝ์ ํ์ฌ ํ์ก์ ์ฃผ์ ํ ํ ์๊ธฐ ๊ฐํ ์บก์ ๋๋ฌ ๋ฐ๋ดํ ์ ์์ผ๋ฏ๋ก, ๋ง๊ฐ ์ ์ฒด๋ฅผ ์ ๊ฑฐํ ํ ํ์ก์ ํฌ์ ํ๊ณ ๋ง๊ฐ๋ฅผ ๋ค์ ๋ฐ๋ด์์ผ์ผ ํ๋ ์ข ๋์ ๋ฐฉ์์ ๋นํ์ฌ ์ฌ์ฉ์ ์ค์ผ์ ์ผ๋ ค๊ฐ ์ ๊ณ ์ฌ์ฉ์ด ๋งค์ฐ ๊ฐํธํ๋ค๊ณ ํ๋ ์ด์ ์ด ์๋ค. In addition, since the opening and closing the cap to open and then insert the needle of the syringe into the injection hole of the opening and closing cap to inject the blood and then press the opening and closing cap to seal, so after removing the entire stopper, the blood is inserted and the stopper Compared with the conventional way of resealing, there is an advantage that there is less concern about contamination and very easy to use.
Claims (13)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110102863A KR101145173B1 (en) | 2011-10-10 | 2011-10-10 | Seperate type platelet rich plasma extraction kit |
KR10-2011-0102863 | 2011-10-10 | ||
KR1020120108913A KR101267379B1 (en) | 2012-09-28 | 2012-09-28 | Platelet rich plasma extraction kit |
KR10-2012-0108913 | 2012-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013055070A2 true WO2013055070A2 (en) | 2013-04-18 |
WO2013055070A3 WO2013055070A3 (en) | 2013-07-04 |
Family
ID=48082637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/008148 WO2013055070A2 (en) | 2011-10-10 | 2012-10-09 | Plasma extraction kit |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013055070A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800007617A1 (en) * | 2018-07-30 | 2020-01-30 | Vettorazzo Marco | SEPARATOR KIT FOR THE EXTRACTION OF PLASMA RICH IN PLATES AND PROCEDURE FOR USING THE KIT |
FR3110390A1 (en) | 2020-05-20 | 2021-11-26 | Cellquest | Device for separating and recovering blood fractions |
CN115870109A (en) * | 2022-12-07 | 2023-03-31 | ไธๆตทๅปๆถฏๅป็็งๆๆ้ๅ ฌๅธ | Horizontal centrifugal rotor, cell separation device and method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8520589B2 (en) * | 2008-05-19 | 2013-08-27 | Motorola Mobility Llc | Mobile device and method for intelligently communicating data generated thereby over short-range, unlicensed wireless networks and wide area wireless networks |
KR101157134B1 (en) * | 2008-10-14 | 2012-06-22 | ์ดํฌ์ | Separating of prp |
KR101069877B1 (en) * | 2009-10-28 | 2011-10-05 | ์๊ธฐํ | Kit of centrifuge separation and methods for centrifuging using the same |
KR20110009651A (en) * | 2010-12-31 | 2011-01-28 | ์ฃผ์ํ์ฌ ๋ฉ๋์ฌ๋ | A blood separating vial, a blood concentrating vial for extracting platelet rich plasma and a method for extracting prp using the same |
-
2012
- 2012-10-09 WO PCT/KR2012/008148 patent/WO2013055070A2/en active Application Filing
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800007617A1 (en) * | 2018-07-30 | 2020-01-30 | Vettorazzo Marco | SEPARATOR KIT FOR THE EXTRACTION OF PLASMA RICH IN PLATES AND PROCEDURE FOR USING THE KIT |
WO2020026008A1 (en) * | 2018-07-30 | 2020-02-06 | VETTORAZZO, Marco | Separation kit for the extraction of platelet-rich plasma and procedure for the use of said kit |
FR3110390A1 (en) | 2020-05-20 | 2021-11-26 | Cellquest | Device for separating and recovering blood fractions |
CN115870109A (en) * | 2022-12-07 | 2023-03-31 | ไธๆตทๅปๆถฏๅป็็งๆๆ้ๅ ฌๅธ | Horizontal centrifugal rotor, cell separation device and method |
CN115870109B (en) * | 2022-12-07 | 2023-08-22 | ไธๆตทๅปๆถฏๅป็็งๆๆ้ๅ ฌๅธ | Horizontal centrifugal rotor, cell separation device and method |
Also Published As
Publication number | Publication date |
---|---|
WO2013055070A3 (en) | 2013-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101110576B1 (en) | Separation and concentration vessel for blood extraction and filler extraction and fibrin production | |
EP2495302B1 (en) | Bio-device for extracting hematopoietic stem cells and mesenchymal stem cells in peripheral blood | |
KR101162750B1 (en) | Tube for blood centrifugation | |
KR101128163B1 (en) | Disposable device for separating platelet rich plasma | |
KR20110009651A (en) | A blood separating vial, a blood concentrating vial for extracting platelet rich plasma and a method for extracting prp using the same | |
KR101125073B1 (en) | One body type apparatus for separation of liquid mixture | |
CN106582908B (en) | A kind of platelet rich plasma fast separation device and method | |
WO2014168409A1 (en) | Blood separation container for extracting self-platelet | |
KR101170146B1 (en) | Seperator and collection apparatus for extracting of platelet rich plasma | |
WO2013133529A1 (en) | Component separator | |
CN106139290B (en) | Integrated autologous platelet rich plasma preparation suit | |
KR101406574B1 (en) | Apparatus for separating blood | |
WO2013055070A2 (en) | Plasma extraction kit | |
US9775942B2 (en) | Buffy coat extraction kit | |
KR20190102064A (en) | Vessel devices for collecting, storing and processing blood or blood compounds | |
CN108654141B (en) | Platelet-rich plasma preparation device | |
KR101433293B1 (en) | Seperator and collection apparatus for extracting of Platelet Rich Plasma | |
WO2019103313A2 (en) | Device for centrifuging blood components | |
CN106310720A (en) | Platelet rich plasma separator | |
KR101267379B1 (en) | Platelet rich plasma extraction kit | |
KR101279652B1 (en) | Device for separating platelet rich plasma with a coagulation catalyst, method for separating and coagulating platelet rich plasma using the same | |
WO2016195126A1 (en) | Blood separation and extraction apparatus for extracting platelet-rich growth factor | |
CN206315325U (en) | Integrated autologous platelet rich plasma preparation suit | |
KR101145173B1 (en) | Seperate type platelet rich plasma extraction kit | |
KR101493830B1 (en) | Device for isolating blood components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12840655 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12840655 Country of ref document: EP Kind code of ref document: A2 |